HTTP 200 OK
Allow: GET, POST, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept
{
"recordsFiltered": 48602,
"recordsTotal": 48602,
"next": "http://staging-fdaaa.ebmdatalab.net/api/trials/?format=api&length=300&ordering=title&start=45900",
"previous": "http://staging-fdaaa.ebmdatalab.net/api/trials/?format=api&length=300&ordering=title&start=45300",
"results": [
{
"registry_id": "NCT06957691",
"publication_url": "https://clinicaltrials.gov/study/NCT06957691",
"title": "Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy (Fezo-ADT Trial)",
"has_exemption": false,
"start_date": "2026-01-14",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Shehzad Basaria, M.D.",
"sponsor_slug": "shehzad-basaria-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07053800",
"publication_url": "https://clinicaltrials.gov/study/NCT07053800",
"title": "A Single-Arm, Open-Label, Phase II Study to Determine the Safety and Efficacy of Obecabtagene Autoleucel (Obe-cel) in Participants With Severe, Refractory Systemic Lupus Erythematosus With Active Lupus Nephritis",
"has_exemption": false,
"start_date": "2026-01-16",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Autolus Limited",
"sponsor_slug": "autolus-limited",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07362017",
"publication_url": "https://clinicaltrials.gov/study/NCT07362017",
"title": "A Multicenter, Open Label Study to Investigate the Safety and Efficacy of Ponesimod in the Treatment of Moderate-to-Severe Chronic Plaque Psoriasis",
"has_exemption": false,
"start_date": "2026-01-31",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Vanda Pharmaceuticals",
"sponsor_slug": "vanda-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06062888",
"publication_url": "https://clinicaltrials.gov/study/NCT06062888",
"title": "Multi-institutional Phase 2/3 Trial of Fresh Frozen Plasma (FFP) in Patients With Moderate to Severe Traumatic Brain Injury (TBI)",
"has_exemption": false,
"start_date": "2026-02-01",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Northwestern University",
"sponsor_slug": "northwestern-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06943859",
"publication_url": "https://clinicaltrials.gov/study/NCT06943859",
"title": "Ketamine for the Treatment of Opioid Use Disorder",
"has_exemption": false,
"start_date": "2026-02-04",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Maryland, Baltimore",
"sponsor_slug": "university-of-maryland-baltimore",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07518004",
"publication_url": "https://clinicaltrials.gov/study/NCT07518004",
"title": "ROME GS System Study: A Prospective, Multicenter Evaluation of Accuracy and Safety of the ROME GS System",
"has_exemption": false,
"start_date": "2026-02-12",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Senseonics, Inc.",
"sponsor_slug": "senseonics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07103746",
"publication_url": "https://clinicaltrials.gov/study/NCT07103746",
"title": "Study of Ublituximab in Early, Active, Autoantibody-Positive, IMMune-MedIated NecroTizing Myopathy (AIM01)",
"has_exemption": false,
"start_date": "2026-02-26",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Allergy and Infectious Diseases (NIAID)",
"sponsor_slug": "national-institute-of-allergy-and-infectious-diseases-niaid",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07273838",
"publication_url": "https://clinicaltrials.gov/study/NCT07273838",
"title": "Sodium-Glucose Cotransporter-2 Inhibitor for Amelioration of Acute Cardiorenal Syndrome: A Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2026-03-05",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07348627",
"publication_url": "https://clinicaltrials.gov/study/NCT07348627",
"title": "Opioid-Sparing Joint Replacement - Single Site Randomized Control Trial",
"has_exemption": false,
"start_date": "2026-03-19",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Emory University",
"sponsor_slug": "emory-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07477639",
"publication_url": "https://clinicaltrials.gov/study/NCT07477639",
"title": "A Phase 1/2a, Open-Label, Dose-Escalation Study to Evaluate the Safety and Preliminary Efficacy of TRX319 in Subjects With Primary or Secondary Progressive Multiple Sclerosis",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Tr1X, Inc.",
"sponsor_slug": "tr1x-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07102940",
"publication_url": "https://clinicaltrials.gov/study/NCT07102940",
"title": "Eftilagimod Alpha in Combination With Neoadjuvant Chemotherapy in Patients With Hormone Receptor Positive/HER2-neg Breast Cancer",
"has_exemption": false,
"start_date": "2026-05-01",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "George Washington University",
"sponsor_slug": "george-washington-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06957418",
"publication_url": "https://clinicaltrials.gov/study/NCT06957418",
"title": "The Alzheimer's Disease Tau Platform Clinical Trial",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Paul S. Aisen",
"sponsor_slug": "paul-s-aisen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07167966",
"publication_url": "https://clinicaltrials.gov/study/NCT07167966",
"title": "Alzheimer's Tau Platform (ATP): Regimen Specific Appendix for AADvac1",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Paul S. Aisen",
"sponsor_slug": "paul-s-aisen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07552558",
"publication_url": "https://clinicaltrials.gov/study/NCT07552558",
"title": "Phase I/II Trial of Neoadjuvant Combination of Ficerafusp Alfa, Pembrolizumab, and SBRT for Locally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06067802",
"publication_url": "https://clinicaltrials.gov/study/NCT06067802",
"title": "A Phase II, Escalating Dose, Open Label Study to Evaluate the Safety of Triheptanoin for the Prevention of Hypoglycemia in Patients With Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCADD)",
"has_exemption": false,
"start_date": "2026-08-31",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Jerry Vockley, MD, PhD",
"sponsor_slug": "jerry-vockley-md-phd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06891781",
"publication_url": "https://clinicaltrials.gov/study/NCT06891781",
"title": "A Prospective, Multi-center, Randomized, Double-blind, Cross Over, Clinical Trial to Compare the Safety and Effectiveness of Adaptive Versus Conventional Stimulation in Levodopa- Responsive Parkinson's Disease Treated With Bilateral Deep Brain Stimulation of the Subthalamic Nucleus",
"has_exemption": false,
"start_date": "2026-08-31",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Newronika",
"sponsor_slug": "newronika",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04056013",
"publication_url": "https://clinicaltrials.gov/study/NCT04056013",
"title": "Vicryl Rapide Versus Nonabsorbable Suture in Repair of Simple Traumatic Extremity and Trunk Lacerations in Adult Patients",
"has_exemption": false,
"start_date": "2019-09-26",
"completion_date": "2028-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04140487",
"publication_url": "https://clinicaltrials.gov/study/NCT04140487",
"title": "A Phase I/II Study of Azacitidine, Venetoclax, and Gilteritinib for Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome With an Activating FLT3 Mutation",
"has_exemption": false,
"start_date": "2019-12-17",
"completion_date": "2028-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04209686",
"publication_url": "https://clinicaltrials.gov/study/NCT04209686",
"title": "Phase 2 Study of Paclitaxel, Pembrolizumab and Olaparib in Previously Treated Advanced Gastric Adenocarcinoma",
"has_exemption": false,
"start_date": "2020-07-31",
"completion_date": "2028-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins",
"sponsor_slug": "sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04408482",
"publication_url": "https://clinicaltrials.gov/study/NCT04408482",
"title": "Does Pancreatic Stent Decrease the Risk of Pancreatitis After Pancreatic Sphincterotomy for Difficult Cannulation?",
"has_exemption": false,
"start_date": "2020-08-01",
"completion_date": "2028-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Helsinki University Central Hospital",
"sponsor_slug": "helsinki-university-central-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05100095",
"publication_url": "https://clinicaltrials.gov/study/NCT05100095",
"title": "Hypofractionated Radiation Therapy for Merkel Cell Carcinoma",
"has_exemption": false,
"start_date": "2021-12-14",
"completion_date": "2028-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05929729",
"publication_url": "https://clinicaltrials.gov/study/NCT05929729",
"title": "Neurovascular and Neurocognitive Consequences of Iron Deficiency Anemia",
"has_exemption": false,
"start_date": "2023-12-07",
"completion_date": "2028-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Hospital Los Angeles",
"sponsor_slug": "childrens-hospital-los-angeles",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06027086",
"publication_url": "https://clinicaltrials.gov/study/NCT06027086",
"title": "A Phase 1b/2 Study of Glutamine Antagonist DRP-104 in Combination With Durvalumab in Patients With Advanced Stage Fibrolamellar Hepatocellular Carcinoma (FLC)",
"has_exemption": false,
"start_date": "2024-02-12",
"completion_date": "2028-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins",
"sponsor_slug": "sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04875702",
"publication_url": "https://clinicaltrials.gov/study/NCT04875702",
"title": "Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in Gout: A Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2024-02-22",
"completion_date": "2028-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05919329",
"publication_url": "https://clinicaltrials.gov/study/NCT05919329",
"title": "Modulation of PSMA Expression in Castration Sensitive and Castration Resistant Prostate Cancer in Response to Hormonal Therapy",
"has_exemption": false,
"start_date": "2024-06-25",
"completion_date": "2028-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "OHSU Knight Cancer Institute",
"sponsor_slug": "ohsu-knight-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06253117",
"publication_url": "https://clinicaltrials.gov/study/NCT06253117",
"title": "Evaluation of Pirfenidone as a Novel Therapeutic Strategy Against Recurrent Acute Pancreatitis.",
"has_exemption": false,
"start_date": "2024-06-27",
"completion_date": "2028-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Alabama at Birmingham",
"sponsor_slug": "university-of-alabama-at-birmingham",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06573996",
"publication_url": "https://clinicaltrials.gov/study/NCT06573996",
"title": "The Effect of Intraoral Transcutaneous Electrical Nerve Stimulation (TENS) on Pain Perception During Orthodontic Alignment and Leveling: A Randomized Clinical Trial",
"has_exemption": false,
"start_date": "2024-09-16",
"completion_date": "2028-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of the Pacific",
"sponsor_slug": "university-of-the-pacific",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06415591",
"publication_url": "https://clinicaltrials.gov/study/NCT06415591",
"title": "Auricular Neuromodulation in Veterans With Fibromyalgia: A Randomized, Sham-Controlled Study",
"has_exemption": false,
"start_date": "2024-11-01",
"completion_date": "2028-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06567314",
"publication_url": "https://clinicaltrials.gov/study/NCT06567314",
"title": "Phase 2 Study of Ivonescimab in Patients With Cutaneous Squamous Cell Carcinoma",
"has_exemption": false,
"start_date": "2024-12-02",
"completion_date": "2028-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06706284",
"publication_url": "https://clinicaltrials.gov/study/NCT06706284",
"title": "Glycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 Diabetes",
"has_exemption": false,
"start_date": "2025-04-11",
"completion_date": "2028-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Marzieh Salehi",
"sponsor_slug": "marzieh-salehi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06883162",
"publication_url": "https://clinicaltrials.gov/study/NCT06883162",
"title": "Randomized Controlled Trial of Varenicline to Treat Tobacco and Cannabis Co-Use (RECLAIM)",
"has_exemption": false,
"start_date": "2025-05-06",
"completion_date": "2028-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical University of South Carolina",
"sponsor_slug": "medical-university-of-south-carolina",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06651593",
"publication_url": "https://clinicaltrials.gov/study/NCT06651593",
"title": "Phase II Biomarker Study of SAR444881 in Combination With Cemiplimab in Solid Tumors",
"has_exemption": false,
"start_date": "2025-07-02",
"completion_date": "2028-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07103616",
"publication_url": "https://clinicaltrials.gov/study/NCT07103616",
"title": "Individual Cerebral Hemodynamic Oxygenation Relationships - ICHOR 4",
"has_exemption": false,
"start_date": "2025-09-01",
"completion_date": "2028-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Hospital Los Angeles",
"sponsor_slug": "childrens-hospital-los-angeles",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07016399",
"publication_url": "https://clinicaltrials.gov/study/NCT07016399",
"title": "A Phase II Neoadjuvant Clinical Trial of the Androgen Receptor Inhibitor Darolutamide in Early-Stage Androgen Receptor Positive (AR+) Triple-Negative Breast Cancer",
"has_exemption": false,
"start_date": "2025-09-09",
"completion_date": "2028-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Vandana Abramson",
"sponsor_slug": "vandana-abramson",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07113743",
"publication_url": "https://clinicaltrials.gov/study/NCT07113743",
"title": "Part B- Phase I/II, Non-Randomized, Single Site Study, Open-label Study of G1XCGD (Lentiviral Vector Transduced CD34+ Cells) in Patients With X-Linked Chronic Granulomatous Disease",
"has_exemption": false,
"start_date": "2025-09-10",
"completion_date": "2028-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Allergy and Infectious Diseases (NIAID)",
"sponsor_slug": "national-institute-of-allergy-and-infectious-diseases-niaid",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07221942",
"publication_url": "https://clinicaltrials.gov/study/NCT07221942",
"title": "Pembrolizumab Maintenance After Enfortumab Vedotin/Pembrolizumab Induction in Front-Line Metastatic Urothelial Carcinoma",
"has_exemption": false,
"start_date": "2026-01-23",
"completion_date": "2028-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Fox Chase Cancer Center",
"sponsor_slug": "fox-chase-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07264868",
"publication_url": "https://clinicaltrials.gov/study/NCT07264868",
"title": "Home Neuromodulation for Neurogenic Bladder Management in Spinal Cord Injury: A Hybrid Implementation-Efficacy Trial",
"has_exemption": false,
"start_date": "2026-02-28",
"completion_date": "2028-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Texas Health Science Center, Houston",
"sponsor_slug": "the-university-of-texas-health-science-center-houston",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07204080",
"publication_url": "https://clinicaltrials.gov/study/NCT07204080",
"title": "Phase II Clinical Trial Evaluating the Safety and Efficacy of Fc-Modified Anti-CD154 mAB (TNX-1500) in Kidney Transplant Recipients",
"has_exemption": false,
"start_date": "2026-07-01",
"completion_date": "2028-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Ayman Al Jurdi, MD",
"sponsor_slug": "ayman-al-jurdi-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07369050",
"publication_url": "https://clinicaltrials.gov/study/NCT07369050",
"title": "Is the Provox ActiValve Only a Problem Solver? A Randomized Trial Comparing Routine Use of the ActiValve to Standard Voice Prostheses After Total Laryngectomy With Tracheoesophageal Puncture",
"has_exemption": false,
"start_date": "2026-07-01",
"completion_date": "2028-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07390968",
"publication_url": "https://clinicaltrials.gov/study/NCT07390968",
"title": "A Phase 2, Multicenter, Double-Blind, Randomized, Controlled Trial of the Safety and Immunogenicity of a Self-Amplifying mRNA COVID-19 Vaccine in Adult Hematopoietic Cell Transplant Recipients",
"has_exemption": false,
"start_date": "2026-09-01",
"completion_date": "2028-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Fred Hutchinson Cancer Center",
"sponsor_slug": "fred-hutchinson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06758401",
"publication_url": "https://clinicaltrials.gov/study/NCT06758401",
"title": "AN OPEN-LABEL, RANDOMIZED, CONTROLLED PHASE 3 STUDY OF SIGVOTATUG VEDOTIN IN COMBINATION WITH PEMBROLIZUMAB COMPARED WITH PEMBROLIZUMAB MONOTHERAPY AS FIRST-LINE TREATMENT IN PARTICIPANTS WITH PD-L1 HIGH (≥50% OF TUMOR CELLS EXPRESSING PD-L1), LOCALLY ADVANCED, UNRESECTABLE, OR METASTATIC NON-SMALL CELL LUNG CANCER (BE6A LUNG-02)",
"has_exemption": false,
"start_date": "2025-07-23",
"completion_date": "2028-09-05",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05599360",
"publication_url": "https://clinicaltrials.gov/study/NCT05599360",
"title": "Vyxeos for Induction of Newly Diagnosed Low- or Intermediate-risk AML Patients, Age 18-70. A Pilot Study",
"has_exemption": false,
"start_date": "2022-08-07",
"completion_date": "2028-09-07",
"has_results": false,
"results_due": false,
"sponsor_name": "Shaare Zedek Medical Center",
"sponsor_slug": "shaare-zedek-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06963827",
"publication_url": "https://clinicaltrials.gov/study/NCT06963827",
"title": "A Phase 3 Multicenter, Randomized, Double-Blind, Placebo Controlled Trial to Evaluate Efficacy and Safety of Mezagitamab (TAK-079) in Study Participants With Primary IgA Nephropathy in Combination With Stable Background Therapy",
"has_exemption": false,
"start_date": "2025-07-15",
"completion_date": "2028-09-07",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07472517",
"publication_url": "https://clinicaltrials.gov/study/NCT07472517",
"title": "DAREON ® -Lung-1: A Phase III Multi-center, Open-label, Randomised Trial of Intravenous Obrixtamig in Combination With Atezolizumab, Carboplatin, and Etoposide vs. Atezolizumab, Carboplatin, and Etoposide as First-line Treatment in Patients With Extensive-stage Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2026-04-13",
"completion_date": "2028-09-09",
"has_results": false,
"results_due": false,
"sponsor_name": "Boehringer Ingelheim",
"sponsor_slug": "boehringer-ingelheim",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05611801",
"publication_url": "https://clinicaltrials.gov/study/NCT05611801",
"title": "AN OPEN-LABEL STUDY IN PEDIATRIC (<18 YEARS OF AGE), SEVERE HEMOPHILIA A PARTICIPANTS (COAGULATION FACTOR ACTIVITY <1%) WITH OR WITHOUT INHIBITORS OR MODERATELY SEVERE TO SEVERE HEMOPHILIA B PARTICIPANTS (COAGULATION FACTOR ACTIVITY ≤2%) WITH OR WITHOUT INHIBITORS COMPARING 12 MONTHS OF HISTORICAL STANDARD TREATMENT TO MARSTACIMAB PROPHYLAXIS",
"has_exemption": false,
"start_date": "2022-12-09",
"completion_date": "2028-09-10",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07473973",
"publication_url": "https://clinicaltrials.gov/study/NCT07473973",
"title": "The ENERGY 2 Study: An Open-Label Phase 3 Study to Evaluate the Efficacy and Safety of INZ-701 in Infants With Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 (ENPP1) Deficiency",
"has_exemption": false,
"start_date": "2025-03-26",
"completion_date": "2028-09-11",
"has_results": false,
"results_due": false,
"sponsor_name": "Inozyme Pharma",
"sponsor_slug": "inozyme-pharma",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06959641",
"publication_url": "https://clinicaltrials.gov/study/NCT06959641",
"title": "A Phase 2 Open Label Study of XL092 as First Line Therapy in Radioiodine Refractory Differentiated Thyroid Cancer",
"has_exemption": false,
"start_date": "2025-06-06",
"completion_date": "2028-09-11",
"has_results": false,
"results_due": false,
"sponsor_name": "Northwestern University",
"sponsor_slug": "northwestern-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06976216",
"publication_url": "https://clinicaltrials.gov/study/NCT06976216",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for the Treatment of Cognitive Impairment Associated With Mild to Moderate Alzheimer's Disease (MINDSET 1)",
"has_exemption": false,
"start_date": "2025-07-14",
"completion_date": "2028-09-11",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06976203",
"publication_url": "https://clinicaltrials.gov/study/NCT06976203",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for the Treatment of Cognitive Impairment Associated With Mild to Moderate Alzheimer's Disease (MINDSET 2)",
"has_exemption": false,
"start_date": "2025-07-21",
"completion_date": "2028-09-11",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06980480",
"publication_url": "https://clinicaltrials.gov/study/NCT06980480",
"title": "A Multicenter, Randomized, Controlled, Open-label, Group-Sequential, Phase 3 Study to Investigate the Efficacy, Safety, and Tolerability of Intravenous Gammagard Liquid (Immune Globulin Infusion, 10%) for Primary Infection Prophylaxis Compared With Secondary Infection Prophylaxis in Adult Subjects With Multiple Myeloma Receiving B-Cell Maturation AntigenxCD3-Directed Bispecific Antibody Therapy",
"has_exemption": false,
"start_date": "2026-01-14",
"completion_date": "2028-09-11",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07028853",
"publication_url": "https://clinicaltrials.gov/study/NCT07028853",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Mevrometostat (PF-06821497) With Enzalutamide in Metastatic Castration-Sensitive Prostate Cancer (MEVPRO-3)",
"has_exemption": false,
"start_date": "2025-09-28",
"completion_date": "2028-09-12",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06847542",
"publication_url": "https://clinicaltrials.gov/study/NCT06847542",
"title": "A Phase IIIb, Multicenter, Single-arm Study Assessing the Effectiveness, Safety and Patient Reported Outcomes of a 36-week Refill Exchange Regimen for the Port Delivery System With Ranibizumab in Patients With Neovascular Age-related Macular Degeneration",
"has_exemption": false,
"start_date": "2025-11-27",
"completion_date": "2028-09-12",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07499544",
"publication_url": "https://clinicaltrials.gov/study/NCT07499544",
"title": "A Multicenter, Randomized, Controlled, Open-label, Phase III Study to Assess Efficacy and Safety of Libevitug Injection in Participants With Chronic Hepatitis Delta Virus Infection (D-clear Study)",
"has_exemption": false,
"start_date": "2026-03-25",
"completion_date": "2028-09-12",
"has_results": false,
"results_due": false,
"sponsor_name": "Huahui Health",
"sponsor_slug": "huahui-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05244486",
"publication_url": "https://clinicaltrials.gov/study/NCT05244486",
"title": "Efficacy of RestoreX Penile Traction Therapy In Preserving Erectile Function Post-Prostatectomy",
"has_exemption": false,
"start_date": "2022-03-12",
"completion_date": "2028-09-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Charitable Union for the Research and Education of Peyronie's Disease",
"sponsor_slug": "charitable-union-for-the-research-and-education-of-peyronies-disease",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06872892",
"publication_url": "https://clinicaltrials.gov/study/NCT06872892",
"title": "A Phase III, Randomised, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety, and Tolerability of BI 1291583 2.5 mg Administered Once Daily for up to 76 Weeks in Patients With Bronchiectasis (The AIRTIVITY™ Study)",
"has_exemption": false,
"start_date": "2025-06-09",
"completion_date": "2028-09-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Boehringer Ingelheim",
"sponsor_slug": "boehringer-ingelheim",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07094516",
"publication_url": "https://clinicaltrials.gov/study/NCT07094516",
"title": "A Randomized, Placebo-controlled, Parallel Group, 72-week Study to Evaluate the Efficacy and Safety of VHB937 in Participants With Early Alzheimer's Disease Followed by an Extension",
"has_exemption": false,
"start_date": "2025-08-07",
"completion_date": "2028-09-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07441278",
"publication_url": "https://clinicaltrials.gov/study/NCT07441278",
"title": "A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose Finding Trial to Evaluate the Efficacy and Safety of Orally Administered NS-863 in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)",
"has_exemption": false,
"start_date": "2026-07-01",
"completion_date": "2028-09-14",
"has_results": false,
"results_due": false,
"sponsor_name": "NS Pharma, Inc.",
"sponsor_slug": "ns-pharma-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06175000",
"publication_url": "https://clinicaltrials.gov/study/NCT06175000",
"title": "Maintenance Obinutuzumab for Primary Central Nervous System Lymphoma Complete or Partial Responders",
"has_exemption": false,
"start_date": "2024-03-13",
"completion_date": "2028-09-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Providence Health & Services",
"sponsor_slug": "providence-health-services",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06158828",
"publication_url": "https://clinicaltrials.gov/study/NCT06158828",
"title": "A Phase I/II Pilot Study of Memory-like NK Cells to Consolidate TCRαβ T Cell Depleted Haploidentical Transplant in High-risk AML",
"has_exemption": false,
"start_date": "2024-05-15",
"completion_date": "2028-09-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06514547",
"publication_url": "https://clinicaltrials.gov/study/NCT06514547",
"title": "Vaccine Immunity and Inflammation in the Aging Person Living With HIV",
"has_exemption": false,
"start_date": "2024-07-08",
"completion_date": "2028-09-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Hennepin Healthcare Research Institute.",
"sponsor_slug": "hennepin-healthcare-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07105709",
"publication_url": "https://clinicaltrials.gov/study/NCT07105709",
"title": "A Multi-Centre, Single Arm, Open-Label Extension Study to Evaluate the Long-term Safety and Efficacy of GSK4527226 (AL101) in Participants With Early Alzheimer's Disease",
"has_exemption": false,
"start_date": "2025-08-14",
"completion_date": "2028-09-15",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07100080",
"publication_url": "https://clinicaltrials.gov/study/NCT07100080",
"title": "IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-based Chemotherapy in Patients With EGFR-mutated Non-small Cell Lung Cancer and Disease Progression on EGFR Tyrosine Kinase Inhibitor Therapy",
"has_exemption": false,
"start_date": "2025-11-05",
"completion_date": "2028-09-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07522073",
"publication_url": "https://clinicaltrials.gov/study/NCT07522073",
"title": "A Randomized, Double-Blind, Phase 3 Study of Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma (DAWN-303)",
"has_exemption": false,
"start_date": "2026-04-09",
"completion_date": "2028-09-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Incyte Corporation",
"sponsor_slug": "incyte-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07015996",
"publication_url": "https://clinicaltrials.gov/study/NCT07015996",
"title": "Efficacy of Tezepelumab in Peanut Oral Immunotherapy: a Double-Blind, Randomized, Placebo-Controlled Trial",
"has_exemption": false,
"start_date": "2026-06-15",
"completion_date": "2028-09-16",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Allergy and Infectious Diseases (NIAID)",
"sponsor_slug": "national-institute-of-allergy-and-infectious-diseases-niaid",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06990529",
"publication_url": "https://clinicaltrials.gov/study/NCT06990529",
"title": "An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Leniolisib for Immune Dysregulation in Primary Immunodeficiency Disorders",
"has_exemption": false,
"start_date": "2025-04-29",
"completion_date": "2028-09-18",
"has_results": false,
"results_due": false,
"sponsor_name": "Pharming Technologies B.V.",
"sponsor_slug": "pharming-technologies-bv",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07228403",
"publication_url": "https://clinicaltrials.gov/study/NCT07228403",
"title": "A 104-week, Multicenter, Open-label, Single-arm, Phase 3 Extension Trial Investigating the Long-term Safety and Efficacy of Glepaglutide in Adult Patients With Short Bowel Syndrome (SBS) Rolling Over From the EASE SBS 2 or 3 Trials",
"has_exemption": false,
"start_date": "2025-12-11",
"completion_date": "2028-09-18",
"has_results": false,
"results_due": false,
"sponsor_name": "Zealand Pharma",
"sponsor_slug": "zealand-pharma",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05239741",
"publication_url": "https://clinicaltrials.gov/study/NCT05239741",
"title": "A Phase 3 Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Chinese Participants With Stage IV Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Colorectal Cancer (MK-3475-C66)",
"has_exemption": false,
"start_date": "2022-04-02",
"completion_date": "2028-09-19",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07196722",
"publication_url": "https://clinicaltrials.gov/study/NCT07196722",
"title": "A Phase 2b/3 Randomized, Double-blind, Placebo-Controlled, Parallel Group, Multicenter Protocol to Evaluate the Efficacy and Safety of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease",
"has_exemption": false,
"start_date": "2025-10-03",
"completion_date": "2028-09-19",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05587712",
"publication_url": "https://clinicaltrials.gov/study/NCT05587712",
"title": "A Phase 2 Open-label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Sotatercept (MK-7962) in Children From 1 to Less Than 18 Years of Age With PAH on Standard of Care",
"has_exemption": false,
"start_date": "2023-01-19",
"completion_date": "2028-09-21",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06057935",
"publication_url": "https://clinicaltrials.gov/study/NCT06057935",
"title": "ICARuS II (Intraperitoneal Chemotherapy After cytoReductive Surgery): A Multicenter, Randomized Phase II Trial of Normothermic Intraperitoneal Chemotherapy and Intravenous Chemotherapy After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma",
"has_exemption": false,
"start_date": "2023-09-21",
"completion_date": "2028-09-21",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07185009",
"publication_url": "https://clinicaltrials.gov/study/NCT07185009",
"title": "A Multicenter, Multinational, Randomized, Double-blind, Placebo-Controlled, Phase 3 Maintenance Study to Evaluate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis",
"has_exemption": false,
"start_date": "2026-01-16",
"completion_date": "2028-09-21",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01499888",
"publication_url": "https://clinicaltrials.gov/study/NCT01499888",
"title": "Phase I/II Study of Allogeneic Stem Cell Transplantation to Treat Clinically Aggressive Sickle Cell Disease (SCD)",
"has_exemption": false,
"start_date": "2011-11-11",
"completion_date": "2028-09-23",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Illinois at Chicago",
"sponsor_slug": "university-of-illinois-at-chicago",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT06882785",
"publication_url": "https://clinicaltrials.gov/study/NCT06882785",
"title": "A Phase 3, Randomized, Two-part Study With a 5-week Double-blind Part (Randomized, Parallelgroup, Placebo-controlled) Followed by a 52-week Open-label Extension Part to Evaluate the Efficacy and Safety of KarXT in Acutely Psychotic Japanese Adult Patients With Diagnostic and Statistical Manual of Mental Disorders-Fifth Edition (DSM-5) Schizophrenia",
"has_exemption": false,
"start_date": "2025-06-10",
"completion_date": "2028-09-23",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06726148",
"publication_url": "https://clinicaltrials.gov/study/NCT06726148",
"title": "An Open-label, Multi-center, Phase I/II Study of ECI830 as a Single Agent and in Combination With Ribociclib and Endocrine Therapy in Patients With Advanced Hormone Receptor Positive, HER2-negative Breast Cancer and Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2025-04-03",
"completion_date": "2028-09-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06321601",
"publication_url": "https://clinicaltrials.gov/study/NCT06321601",
"title": "A Phase 3, Open-label, Uncontrolled Single-arm Study to Evaluate the Efficacy, Pharmacokinetics, and Safety of Avacopan in Combination With a Rituximab or a Cyclophosphamide-containing Regimen in Children From 6 Years to < 18 Years of Age With Active ANCA-associated Vasculitis (AAV)",
"has_exemption": false,
"start_date": "2024-10-22",
"completion_date": "2028-09-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Amgen",
"sponsor_slug": "amgen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07460752",
"publication_url": "https://clinicaltrials.gov/study/NCT07460752",
"title": "MC250301, OptiOFS: A Randomized Phase II Trial of Alternative Site Goserelin Acetate Injection for Ovarian Function Suppression (OFS) in Local and Locally Advanced Premenopausal Breast Cancer",
"has_exemption": false,
"start_date": "2026-03-24",
"completion_date": "2028-09-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06687603",
"publication_url": "https://clinicaltrials.gov/study/NCT06687603",
"title": "Multi-Site Detection of Barrett's Esophagus in Patients Without Chronic GERD Symptoms",
"has_exemption": false,
"start_date": "2025-03-10",
"completion_date": "2028-09-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Case Comprehensive Cancer Center",
"sponsor_slug": "case-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07213609",
"publication_url": "https://clinicaltrials.gov/study/NCT07213609",
"title": "A Phase 1/2 Open-label, Multicenter Study of Oral GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Adult Participants With Mismatch Repair-deficient (dMMR) or Microsatellite Instability-High (MSI-H) Solid Tumors",
"has_exemption": false,
"start_date": "2025-10-20",
"completion_date": "2028-09-28",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05351801",
"publication_url": "https://clinicaltrials.gov/study/NCT05351801",
"title": "Proof of Concept Trial of Cannabis Derivatives in Neuropathic Pain",
"has_exemption": false,
"start_date": "2023-06-21",
"completion_date": "2028-09-29",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06143891",
"publication_url": "https://clinicaltrials.gov/study/NCT06143891",
"title": "A Randomized, Double-blind, Multicenter, Phase 3 Study to Evaluate Efficacy and Safety of Belumosudil in Combination With Corticosteroids Versus Placebo in Combination With Corticosteroids in Participants at Least 12 Years of Age With Newly Diagnosed Chronic Graft Versus Host Disease (cGVHD)",
"has_exemption": false,
"start_date": "2024-01-23",
"completion_date": "2028-09-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06855277",
"publication_url": "https://clinicaltrials.gov/study/NCT06855277",
"title": "A Phase III, Open-label, Multi-center, Randomized Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive Metastatic Castration Resistant Prostate Cancer",
"has_exemption": false,
"start_date": "2025-07-01",
"completion_date": "2028-09-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07288073",
"publication_url": "https://clinicaltrials.gov/study/NCT07288073",
"title": "A Feasibility Study of Tumor Infiltrating Lymphocytes in Cutaneous Squamous Cell Carcinoma and Merkel Cell Carcinoma",
"has_exemption": false,
"start_date": "2026-02-10",
"completion_date": "2028-09-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Karam Khaddour, MD, MS",
"sponsor_slug": "karam-khaddour-md-ms",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01697371",
"publication_url": "https://clinicaltrials.gov/study/NCT01697371",
"title": "Phase I-II Trial of Stereotactic Body Proton Therapy for Patients With Liver Metastases",
"has_exemption": false,
"start_date": "2012-08-22",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Loma Linda University",
"sponsor_slug": "loma-linda-university",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT01912651",
"publication_url": "https://clinicaltrials.gov/study/NCT01912651",
"title": "The Role of Antibiotics in Full Thickness Skin Graft Survival for Facial Reconstructive Surgery",
"has_exemption": false,
"start_date": "2013-07-31",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Michigan",
"sponsor_slug": "university-of-michigan",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02796937",
"publication_url": "https://clinicaltrials.gov/study/NCT02796937",
"title": "An Open-Label, Multicenter Study to Evaluate the Long-term Safety of Weekly Intravenous Alpha1-Proteinase Inhibitor (Human), Modified Process 60 mg/kg in Subjects With Pulmonary Emphysema Due to Alpha1-Antitrypsin Deficiency",
"has_exemption": false,
"start_date": "2016-07-31",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Grifols Therapeutics LLC",
"sponsor_slug": "grifols-therapeutics-llc",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03398135",
"publication_url": "https://clinicaltrials.gov/study/NCT03398135",
"title": "A Multicenter, Randomized, Double-Blind, Placebo Controlled 52-Week Maintenance and an Open-Label Extension Study of the Efficacy and Safety of Risankizumab in Subjects With Ulcerative Colitis",
"has_exemption": false,
"start_date": "2018-08-28",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04375033",
"publication_url": "https://clinicaltrials.gov/study/NCT04375033",
"title": "CSP #2014 - Comparative Effectiveness of Two Formulations of Buprenorphine for Treating Opioid Use Disorder in Veterans (VA-BRAVE)",
"has_exemption": false,
"start_date": "2020-11-03",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04545736",
"publication_url": "https://clinicaltrials.gov/study/NCT04545736",
"title": "Oral Metformin for Treatment of ABCA4 Retinopathy",
"has_exemption": false,
"start_date": "2020-11-23",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "National Eye Institute (NEI)",
"sponsor_slug": "national-eye-institute-nei",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04535271",
"publication_url": "https://clinicaltrials.gov/study/NCT04535271",
"title": "TAGGED: A Phase 2 Study Using Low Dose/Metronomic Trabectedin, Gemcitabine, and Dacarbazine as 2nd/3rd/4th Line Therapy for Advanced Soft Tissue Sarcoma",
"has_exemption": false,
"start_date": "2021-09-09",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Sarcoma Oncology Research Center, LLC",
"sponsor_slug": "sarcoma-oncology-research-center-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04914507",
"publication_url": "https://clinicaltrials.gov/study/NCT04914507",
"title": "A Prospective Analysis of Long-Term Clinical Outcomes and 3D Spine Growth in Anterior Vertebral Body Tethering",
"has_exemption": false,
"start_date": "2021-09-09",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Pediatric Spine Foundation",
"sponsor_slug": "pediatric-spine-foundation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04526938",
"publication_url": "https://clinicaltrials.gov/study/NCT04526938",
"title": "Clinical Outcomes, Radiation Dosage, and Quality of Life in Patients Treated With Fenestrated Stent Grafts for Complex Thoracoabdominal and Abdominal Aortic Aneurysms, Thoracoabdominal Aortic Aneurysms Secondary to Aortic Dissections",
"has_exemption": false,
"start_date": "2021-09-20",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Medstar Health Research Institute",
"sponsor_slug": "medstar-health-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04372615",
"publication_url": "https://clinicaltrials.gov/study/NCT04372615",
"title": "A Phase-2b, Double-Blind, Randomized Controlled Trial to Evaluate the Activity and Safety of Inebilizumab in Anti-Nmda Receptor Encephalitis and Assess Markers of Disease",
"has_exemption": false,
"start_date": "2022-03-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Utah",
"sponsor_slug": "university-of-utah",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05197881",
"publication_url": "https://clinicaltrials.gov/study/NCT05197881",
"title": "Daily Adaptive External Beam Radiation Therapy in the Treatment of Carcinoma of the Cervix: A Prospective Trial of an Individualized Approach for Intestinal Toxicity Reduction (ARTIA-Cervix)",
"has_exemption": false,
"start_date": "2022-05-03",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Varian, a Siemens Healthineers Company",
"sponsor_slug": "varian-a-siemens-healthineers-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05613413",
"publication_url": "https://clinicaltrials.gov/study/NCT05613413",
"title": "LUNG-IST-127: A Pilot Phase II Study of Maintenance Cabozantinib Plus Pembrolizumab (CP) for Patients With Metastatic sqNSCLC With Disease Control Following Induction Therapy",
"has_exemption": false,
"start_date": "2022-12-28",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Illinois at Chicago",
"sponsor_slug": "university-of-illinois-at-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05765812",
"publication_url": "https://clinicaltrials.gov/study/NCT05765812",
"title": "A Phase 1/2 Open-label Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma",
"has_exemption": false,
"start_date": "2023-05-15",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Debiopharm International SA",
"sponsor_slug": "debiopharm-international-sa",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05941052",
"publication_url": "https://clinicaltrials.gov/study/NCT05941052",
"title": "Supporting, Mobilizing and Accelerating Research for Tuberculosis Elimination (SMART4TB)- Technical Area (TA) 1: Diagnostics- Assessing Diagnostics At Point-of-care for Tuberculosis (ADAPT)",
"has_exemption": false,
"start_date": "2023-08-28",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05979441",
"publication_url": "https://clinicaltrials.gov/study/NCT05979441",
"title": "A Phase 3, Single-Arm, Multicenter, Open-label Extension of Study ARGX-113-2007 to Investigate the Long-term Safety, Tolerability, and Efficacy of Efgartigimod PH20 SC in Participants Aged 18 Years and Older With Active Idiopathic Inflammatory Myopathy",
"has_exemption": false,
"start_date": "2023-09-12",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "argenx",
"sponsor_slug": "argenx",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05934487",
"publication_url": "https://clinicaltrials.gov/study/NCT05934487",
"title": "A Prospective, Multi-Center, Open Label, Randomized Control Clinical Trial Evaluating the Safety and Efficacy of the Cordella™ Pulmonary Artery Sensor System in New York Heart Association (NYHA) Class II-III Heart Failure Patients",
"has_exemption": false,
"start_date": "2023-11-29",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Endotronix, Inc.",
"sponsor_slug": "endotronix-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06056583",
"publication_url": "https://clinicaltrials.gov/study/NCT06056583",
"title": "Postpartum Activity and Expression of BCRP and OCT1 Drug Transporters in the Mammary Gland",
"has_exemption": false,
"start_date": "2023-12-04",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Washington",
"sponsor_slug": "university-of-washington",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05828069",
"publication_url": "https://clinicaltrials.gov/study/NCT05828069",
"title": "Phase 2 Study of Tovorafenib (DAY101) in Relapsed and Refractory Langerhans Cell Histiocytosis",
"has_exemption": false,
"start_date": "2024-03-28",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06128356",
"publication_url": "https://clinicaltrials.gov/study/NCT06128356",
"title": "Pilot Study of Dexmedetomidine Sublingual Film for the Ambulatory Treatment of Hyperadrenergic Autonomic Crisis in Patients With Familial Dysautonomia",
"has_exemption": false,
"start_date": "2024-06-01",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "NYU Langone Health",
"sponsor_slug": "nyu-langone-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06226883",
"publication_url": "https://clinicaltrials.gov/study/NCT06226883",
"title": "A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of 3 Active Dose Regimens of MORF-057 in Adults With Moderately to Severely Active Crohn's Disease (GARNET)",
"has_exemption": false,
"start_date": "2024-07-18",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)",
"sponsor_slug": "morphic-therapeutic-inc-a-wholly-owned-subsidiary-of-eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06464692",
"publication_url": "https://clinicaltrials.gov/study/NCT06464692",
"title": "A Phase 1b Study to Evaluate Safety and Pharmacokinetics (PK) of Telisotuzumab Adizutecan (ABBV-400) in Chinese Subjects With Unresectable Locally Advanced/Metastatic Colorectal Cancer",
"has_exemption": false,
"start_date": "2024-09-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06454188",
"publication_url": "https://clinicaltrials.gov/study/NCT06454188",
"title": "A Randomized, Placebo-controlled, Multicenter, Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients With Active Psoriatic Arthritis (UP-SPOUT)",
"has_exemption": false,
"start_date": "2024-12-03",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "CARE ARTHRITIS LTD.",
"sponsor_slug": "care-arthritis-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06083480",
"publication_url": "https://clinicaltrials.gov/study/NCT06083480",
"title": "Reducing Perioperative Oxidative Stress to Prevent Postoperative Chronic Pain Following Total Knee Arthroplasty",
"has_exemption": false,
"start_date": "2024-12-06",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Vanderbilt University Medical Center",
"sponsor_slug": "vanderbilt-university-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06463028",
"publication_url": "https://clinicaltrials.gov/study/NCT06463028",
"title": "An Open-label, Multi-Center, Phase 2 Clinical Trial Evaluating Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel, and a Substudy Evaluating PIKTOR With Paclitaxel Plus an Insulin-Suppressing Diet, in Patients With Advanced or Recurrent Endometrial Cancer",
"has_exemption": false,
"start_date": "2024-12-12",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Faeth Therapeutics",
"sponsor_slug": "faeth-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06699212",
"publication_url": "https://clinicaltrials.gov/study/NCT06699212",
"title": "A Phase 3 Multicenter, Randomized, Open-label Study of ASP-1929 Photoimmunotherapy in Combination With Pembrolizumab Versus Standard of Care in the First-line Treatment of Patients With Locoregional Recurrence of Squamous Cell Carcinoma of the Head and Neck (HNSCC) With No Distant Metastases",
"has_exemption": false,
"start_date": "2024-12-24",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Rakuten Medical, Inc.",
"sponsor_slug": "rakuten-medical-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05046106",
"publication_url": "https://clinicaltrials.gov/study/NCT05046106",
"title": "A Randomized, Double-Blind, Placebo-Controlled, Dose-Response Efficacy and Safety Study of MLC1501 in Patients With Stroke",
"has_exemption": false,
"start_date": "2025-01-31",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Moleac Pte Ltd.",
"sponsor_slug": "moleac-pte-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06931561",
"publication_url": "https://clinicaltrials.gov/study/NCT06931561",
"title": "Occupational Cancer Screening in Firefighters: A Pilot Study Within the Inova Health System",
"has_exemption": false,
"start_date": "2025-02-11",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Inova Health Care Services",
"sponsor_slug": "inova-health-care-services",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06649058",
"publication_url": "https://clinicaltrials.gov/study/NCT06649058",
"title": "EXCLAIM: Exploring Combined Local and Systemic Approaches In Brain Metastasis: a Multi-cohort Randomized Phase II Study Evaluating Initial Response to Systemic Therapy and Subsequent Integration of Stereotactic Radiosurgery in Patients With Low-risk Brain Metastases and Central Nervous System-active Systemic Therapy Options",
"has_exemption": false,
"start_date": "2025-02-14",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06847321",
"publication_url": "https://clinicaltrials.gov/study/NCT06847321",
"title": "A Randomized, Double-Blind, Placebo-Controlled Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease",
"has_exemption": false,
"start_date": "2025-02-17",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Lighthouse Pharmaceuticals, Inc.",
"sponsor_slug": "lighthouse-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06236607",
"publication_url": "https://clinicaltrials.gov/study/NCT06236607",
"title": "Hybrid Closed Loop Effectiveness Trial in Adults With Type 1 Diabetes",
"has_exemption": false,
"start_date": "2025-02-27",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Boston Medical Center",
"sponsor_slug": "boston-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06406777",
"publication_url": "https://clinicaltrials.gov/study/NCT06406777",
"title": "Validation of MRI, CT and Pulmonary Function Tests for Early Detection of Chronic Lung Allograft Dysfunction",
"has_exemption": false,
"start_date": "2025-03-20",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Sean Fain",
"sponsor_slug": "sean-fain",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05940493",
"publication_url": "https://clinicaltrials.gov/study/NCT05940493",
"title": "A Phase 2 Multicenter, Double-blind, Randomized-controlled Study of Abemaciclib (CDK4 and 6 Inhibitor) in Newly Diagnosed RB-proficient Grade 3 Meningioma Participants",
"has_exemption": false,
"start_date": "2025-03-24",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Nader Sanai",
"sponsor_slug": "nader-sanai",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06901531",
"publication_url": "https://clinicaltrials.gov/study/NCT06901531",
"title": "A Phase 3, Double-blind, Randomized Study of Zolbetuximab in Combination With Pembrolizumab and Chemotherapy (CAPOX or mFOLFOX6) in First-line Treatment of Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma in Participants Whose Tumors Are HER2-negative, Claudin (CLDN) 18.2-positive and Programmed Death-ligand 1 (PD-L1)-Positive",
"has_exemption": false,
"start_date": "2025-05-22",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Astellas Pharma Global Development, Inc.",
"sponsor_slug": "astellas-pharma-global-development-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06880744",
"publication_url": "https://clinicaltrials.gov/study/NCT06880744",
"title": "Phase 3b, Multicenter, Randomized, Open-Label Study of Risankizumab Compared to Vedolizumab for the Treatment of Adult Subjects With Moderate to Severe Ulcerative Colitis Who Are Naïve to Targeted Therapies",
"has_exemption": false,
"start_date": "2025-06-17",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06649695",
"publication_url": "https://clinicaltrials.gov/study/NCT06649695",
"title": "A Phase II Trial of Teclistamab in Participants With Previously Treated Immunoglobulin Light-chain (AL) Amyloidosis",
"has_exemption": false,
"start_date": "2025-07-02",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "European Myeloma Network B.V.",
"sponsor_slug": "european-myeloma-network-bv",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07047716",
"publication_url": "https://clinicaltrials.gov/study/NCT07047716",
"title": "A Phase 3, Single-Arm Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Once-Yearly Intramuscular Lenacapavir for HIV Pre-exposure Prophylaxis (PrEP) in People With an Indication for PrEP",
"has_exemption": false,
"start_date": "2025-07-22",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Gilead Sciences",
"sponsor_slug": "gilead-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07179601",
"publication_url": "https://clinicaltrials.gov/study/NCT07179601",
"title": "Hemorrhoidal Artery Embolization: Longitudinal Impact On Symptoms (HELIOS)",
"has_exemption": false,
"start_date": "2025-08-05",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, Los Angeles",
"sponsor_slug": "university-of-california-los-angeles",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06799494",
"publication_url": "https://clinicaltrials.gov/study/NCT06799494",
"title": "Comparing the Antibody and B Cell Responses Induced by 1- or 2-dose 9-valent HPV (9vHPV) Vaccination in Healthy Adults",
"has_exemption": false,
"start_date": "2025-08-06",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Emory University",
"sponsor_slug": "emory-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07128589",
"publication_url": "https://clinicaltrials.gov/study/NCT07128589",
"title": "Clinical Evaluation of 3M(TM) Filtek(TM) Supreme Flowable Composites for Class IV and Veneers",
"has_exemption": false,
"start_date": "2025-08-07",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "New York University",
"sponsor_slug": "new-york-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06070012",
"publication_url": "https://clinicaltrials.gov/study/NCT06070012",
"title": "Phase II Open-label, Multi-center Study of Tebentafusp in HLA-A*0201 Positive Previously Untreated Metastatic Uveal Melanoma (mUM) With Integrated Circulating Tumor DNA (ctDNA) Biomarker (TARGET-tebe)",
"has_exemption": false,
"start_date": "2025-08-18",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Diwakar Davar",
"sponsor_slug": "diwakar-davar",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06833320",
"publication_url": "https://clinicaltrials.gov/study/NCT06833320",
"title": "A Double-blind, Prospective, Randomized Trial of Propranolol for the Treatment of Postoperative Chylothorax After Open Cardiac Surgery",
"has_exemption": false,
"start_date": "2025-09-09",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "June Wu",
"sponsor_slug": "june-wu",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07174908",
"publication_url": "https://clinicaltrials.gov/study/NCT07174908",
"title": "A Phase 3 Multicenter, Randomized, Controlled, and Open-Label Study of IN10018 in Combination With D-1553 Versus Standard Therapy for the Treatment of First Line Locally-advanced or Metastatic Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation",
"has_exemption": false,
"start_date": "2025-09-10",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "InxMed (Shanghai) Co., Ltd.",
"sponsor_slug": "inxmed-shanghai-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07197827",
"publication_url": "https://clinicaltrials.gov/study/NCT07197827",
"title": "A Phase 1/2, Multicenter, Open-Label, First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of YL242 Monotherapy and Combinations in Advanced Solid Tumors.",
"has_exemption": false,
"start_date": "2025-09-22",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "MediLink Therapeutics (Suzhou) Co., Ltd.",
"sponsor_slug": "medilink-therapeutics-suzhou-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06956209",
"publication_url": "https://clinicaltrials.gov/study/NCT06956209",
"title": "A First-in-Human, Open-Label, Multicenter Study Evaluating the Safety and Efficacy of an Implantable Device for Direct Bladder Wall Stimulation in Participants With Lower Urinary Tract Symptoms of Underactive Bladder",
"has_exemption": false,
"start_date": "2025-09-24",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Iota Biosciences, Inc",
"sponsor_slug": "iota-biosciences-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07043608",
"publication_url": "https://clinicaltrials.gov/study/NCT07043608",
"title": "A Phase II Study of Zanzalintinib for Metastatic Clear Cell Renal Cell Carcinoma With Bone Metastases in Patients Previously Treated With Immune Checkpoint Inhibitors",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Kelly Fitzgerald, MD",
"sponsor_slug": "kelly-fitzgerald-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07101809",
"publication_url": "https://clinicaltrials.gov/study/NCT07101809",
"title": "Evaluating the Safety and Effectiveness of Steerable Ureteroscopic Renal Evacuation (SURE) With the CVAC® System Compared to Standard Ureteroscopy With no Suction for the Treatment of Renal Stones: a Prospective, Randomized Trial",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Calyxo, Inc.",
"sponsor_slug": "calyxo-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07157865",
"publication_url": "https://clinicaltrials.gov/study/NCT07157865",
"title": "A Comparison of Prism Adaptation Training (PAT) Paired With Transcutaneous Electrical Stimulation (TENS) vs PAT Alone on Outcomes in Post-Stroke Patients Experiencing Unilateral Spatial Neglect (USN)",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Kettering Health Network",
"sponsor_slug": "kettering-health-network",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07201298",
"publication_url": "https://clinicaltrials.gov/study/NCT07201298",
"title": "A Prospective Contralateral Comparison of Ray-Tracing Guided LASIK (WaveLight® Plus LASIK) vs. Small Incision Lenticule Extraction (SMILE® Pro) Using VisuMax® 800, or Wavefront Optimized LASIK or Topography Guided LASIK (Contoura LASIK): A Three-Phase Visual Outcomes Study.",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoopes Vision",
"sponsor_slug": "hoopes-vision",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07183644",
"publication_url": "https://clinicaltrials.gov/study/NCT07183644",
"title": "Maximizing Laser Therapy Success for Port-Wine Birthmarks in Pediatric Patients",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas Southwestern Medical Center",
"sponsor_slug": "university-of-texas-southwestern-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06745908",
"publication_url": "https://clinicaltrials.gov/study/NCT06745908",
"title": "ResQ201A-NSCLC: Phase 3 Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint Inhibitor Therapy",
"has_exemption": false,
"start_date": "2025-10-01",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "ImmunityBio, Inc.",
"sponsor_slug": "immunitybio-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07070219",
"publication_url": "https://clinicaltrials.gov/study/NCT07070219",
"title": "A Single-Arm, Open-Label, Multi-Center, Phase 1b/ 2 Study to Evaluate the Safety, Efficacy, and Cellular Pharmacokinetic Profile of CTD402 in Participants With Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia (T-ALL) and Lymphoblastic Lymphoma (T-LBL) (TENACITY-01)",
"has_exemption": false,
"start_date": "2025-10-07",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "BIOHENG THERAPEUTICS US LLC",
"sponsor_slug": "bioheng-therapeutics-us-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07112183",
"publication_url": "https://clinicaltrials.gov/study/NCT07112183",
"title": "An Open Label Study to Assess Efficacy of Oral Treprostinil Titrated to 3.0mg Three Times Daily or Highest Tolerable Dose in 30 Patients With Symptomatic Primary or Secondary Raynaud's Phenomenon Resistant to Standard Vasodilatory Therapy",
"has_exemption": false,
"start_date": "2025-10-15",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Brigham and Women's Hospital",
"sponsor_slug": "brigham-and-womens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06983470",
"publication_url": "https://clinicaltrials.gov/study/NCT06983470",
"title": "Predictive Utility and Mechanisms of Sacral Evoked Responses in Sacral Neuromodulation",
"has_exemption": false,
"start_date": "2025-10-16",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Michigan",
"sponsor_slug": "university-of-michigan",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07224542",
"publication_url": "https://clinicaltrials.gov/study/NCT07224542",
"title": "Smart Soft Contact Lenses for Continuous 24-hour Monitoring of Intraocular Pressure in Glaucoma Care",
"has_exemption": false,
"start_date": "2025-10-19",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Indiana University",
"sponsor_slug": "indiana-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07256392",
"publication_url": "https://clinicaltrials.gov/study/NCT07256392",
"title": "A Phase 3b Long-term Efficacy and Safety Extension Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria Who Have Completed CDX0159-12 or CDX0159-13",
"has_exemption": false,
"start_date": "2025-11-25",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Celldex Therapeutics",
"sponsor_slug": "celldex-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07132190",
"publication_url": "https://clinicaltrials.gov/study/NCT07132190",
"title": "A Double-Blind Phase II Randomized Study of Adaptively Delivered LINAC-Based Stereotactic Radiation for Volatile Brain Metastases With Same-Day Planning and Margin Reduction",
"has_exemption": false,
"start_date": "2025-12-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Ayal A. Aizer, MD",
"sponsor_slug": "ayal-a-aizer-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07160205",
"publication_url": "https://clinicaltrials.gov/study/NCT07160205",
"title": "A Phase 2-Phase 3, Double-blinded, Randomized, Dose-repeating, Cross-over Study to Assess the Safety and Efficacy of Allogeneic ULSC on Disease Severity and Steroid Tapering in Participants With Dermatomyositis/ Polymyositis (DM/PM)",
"has_exemption": false,
"start_date": "2026-01-06",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Restem, LLC.",
"sponsor_slug": "restem-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07049055",
"publication_url": "https://clinicaltrials.gov/study/NCT07049055",
"title": "A Phase I/IIa Randomized Clinical Trial to Evaluate the Efficacy of EGFR-targeted, PNU-159682-packaged Nanocells & Glycolipid-Packaged Nanocells in Combination With Gemcitabine & Nab-paclitaxel in Metastatic Pancreatic Ductal Adenocarcinoma",
"has_exemption": false,
"start_date": "2026-01-12",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Engeneic Pty Limited",
"sponsor_slug": "engeneic-pty-limited",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07214311",
"publication_url": "https://clinicaltrials.gov/study/NCT07214311",
"title": "RETAIN: A Phase 2/3 Randomized, Placebo-Controlled Study to Evaluate the Efficacy of PLG0206 in Prevention of Recurrent Infection in Patients Undergoing Debridement, Antibiotics, and Implant Retention (DAIR) for Treatment of a Periprosthetic Joint Infection (PJI) Following Total Knee Arthroplasty (TKA)",
"has_exemption": false,
"start_date": "2026-02-03",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Peptilogics",
"sponsor_slug": "peptilogics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07226791",
"publication_url": "https://clinicaltrials.gov/study/NCT07226791",
"title": "A Phase 2 Double-Blind, Placebo-Controlled, Adaptive, Dose-Escalation Study to Evaluate the Safety and Efficacy of AGN-151607-DP (USAN: gemibotulinumtoxinA) for the Achievement of Primary Fascial Closure Without the Use of Component Separation Technique, in Subjects Undergoing Open Abdominal Ventral Hernia Repair",
"has_exemption": false,
"start_date": "2026-02-04",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07282847",
"publication_url": "https://clinicaltrials.gov/study/NCT07282847",
"title": "A Single-Arm, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability and Efficacy of a Single Intravenous Infusion of AB-1009 in Adult Participants With Late Onset Pompe Disease (LOPD)",
"has_exemption": false,
"start_date": "2026-02-10",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "AskBio Inc",
"sponsor_slug": "askbio-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07186660",
"publication_url": "https://clinicaltrials.gov/study/NCT07186660",
"title": "Evaluation of a Novel Insulin Sensitizer on Glycemic Control, Insulin Usage, and Cardiovascular Biomarkers in People With Type 1 Diabetes Who Use Closed-loop Automated Insulin Delivery",
"has_exemption": false,
"start_date": "2026-02-22",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Virginia",
"sponsor_slug": "university-of-virginia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06451757",
"publication_url": "https://clinicaltrials.gov/study/NCT06451757",
"title": "A Phase III, Randomised, Double-blind, Placebo-controlled, Parallel-group, Pivotal Trial to Assess the Efficacy and Safety of Sonlicromanol in Adult Subjects With a Genetically Confirmed Mitochondrial DNA tRNALeu(UUR) m.3243A>G Variant",
"has_exemption": false,
"start_date": "2026-02-28",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Khondrion BV",
"sponsor_slug": "khondrion-bv",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07182227",
"publication_url": "https://clinicaltrials.gov/study/NCT07182227",
"title": "A Phase 1/2 Multicenter, Open Label, Two-part Study (Single Ascending Dose [Part 1], and Dose Expansion [Part 2]) to Evaluate Safety, Tolerability and Efficacy of PS-002, a Gene Therapy for the Treatment of Adult Participants With Primary IgA Nephropathy",
"has_exemption": false,
"start_date": "2026-02-28",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Purespring Therapeutics Limited",
"sponsor_slug": "purespring-therapeutics-limited",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06904378",
"publication_url": "https://clinicaltrials.gov/study/NCT06904378",
"title": "Phase I/II Clinical Trial of ONT01 and Gemcitabine/Nab-paclitaxel as Second Line Therapy for Metastatic Pancreatic Ductal Adenocarcinoma: Reprogramming Tumor-associated Myeloid Cells",
"has_exemption": false,
"start_date": "2026-03-25",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07431099",
"publication_url": "https://clinicaltrials.gov/study/NCT07431099",
"title": "Skin Color Matching in Head and Neck Reconstructive Surgery Using RECELL® Autologous Skin Cell Suspension: A Prospective, Pilot Study",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07439172",
"publication_url": "https://clinicaltrials.gov/study/NCT07439172",
"title": "A Multi-Centered Evaluation of Pre-Radiation Chemotherapy for Newly Diagnosed High-Grade Glioma (HGG): An Approach to Drug Screening That Requires Confirmation",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "The Cooper Health System",
"sponsor_slug": "the-cooper-health-system",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07278479",
"publication_url": "https://clinicaltrials.gov/study/NCT07278479",
"title": "A Phase 1/2a Study to Assess Safety, Tolerability, and Efficacy of [212Pb]Pb-DOTAM-MAM279 in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors",
"has_exemption": false,
"start_date": "2026-04-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Molecular Partners AG",
"sponsor_slug": "molecular-partners-ag",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07144150",
"publication_url": "https://clinicaltrials.gov/study/NCT07144150",
"title": "Advance Evero™ 18 Everolimus-Coated Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter Versus Paclitaxel-coated Ballons in Patients With Femoropopliteal Disease (EVERO Trial)",
"has_exemption": false,
"start_date": "2026-05-31",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Cook Research Incorporated",
"sponsor_slug": "cook-research-incorporated",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07539311",
"publication_url": "https://clinicaltrials.gov/study/NCT07539311",
"title": "A Phase 2, Open-label, Multicohort, Study of Rinatabart Sesutecan (Rina S) in Participants With Advanced Gastrointestinal (GI) Cancers",
"has_exemption": false,
"start_date": "2026-05-31",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Genmab",
"sponsor_slug": "genmab",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05249556",
"publication_url": "https://clinicaltrials.gov/study/NCT05249556",
"title": "Double-blind, Randomized, Placebo-controlled Trial of Adjunctive Ganaxolone in the Treatment of Seizures Associated With Genetically Confirmed Cyclin-dependent Kinase-like 5 (CDKL5) Deficiency Disorder (CDD) in Pediatric Patients From 6 Months to Less Than 2 Years of Age.",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Immedica Pharma AB",
"sponsor_slug": "immedica-pharma-ab",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07006805",
"publication_url": "https://clinicaltrials.gov/study/NCT07006805",
"title": "RESET-MS: A Phase 1/2, Open-Label Study to Evaluate the Safety and Efficacy of Autologous CD19-specific Chimeric Antigen Receptor T Cells (CABA-201) in Participants With Multiple Sclerosis",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Cabaletta Bio",
"sponsor_slug": "cabaletta-bio",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07429266",
"publication_url": "https://clinicaltrials.gov/study/NCT07429266",
"title": "A Phase 3 Randomized, Double-blind, Placebo-controlled Global Study of Sapablursen in Polycythemia Vera",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Ono Pharmaceutical Co. Ltd",
"sponsor_slug": "ono-pharmaceutical-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07550088",
"publication_url": "https://clinicaltrials.gov/study/NCT07550088",
"title": "A Single-Arm, Phase II Study Evaluating Combination Balstilimab Plus Botensilimab With AgenT-797 in Previously Treated Patients With pMMR Metastatic CRC With Liver Metastases",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Darren Sigal, MD",
"sponsor_slug": "darren-sigal-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06979076",
"publication_url": "https://clinicaltrials.gov/study/NCT06979076",
"title": "A Phase Ib Study of the Selective PKC-β Inhibitor MS-553 in Patients With Refractory or Relapsed Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma",
"has_exemption": false,
"start_date": "2026-07-31",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "MingSight Pharmaceuticals, Inc.",
"sponsor_slug": "mingsight-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07223528",
"publication_url": "https://clinicaltrials.gov/study/NCT07223528",
"title": "A Phase 2a Single Arm Open Label Safety and Efficacy Study of Telaglenastat Plus Standard of Care in Adults With Functional Class Ii-iii Precapillary Pulmonary Hypertension Across Wsph Groups 1-4",
"has_exemption": false,
"start_date": "2026-08-31",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Chan, Stephen, MD, PhD",
"sponsor_slug": "chan-stephen-md-phd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05864313",
"publication_url": "https://clinicaltrials.gov/study/NCT05864313",
"title": "Gaze and Gait Training With Neuromodulation",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Florida",
"sponsor_slug": "university-of-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06712433",
"publication_url": "https://clinicaltrials.gov/study/NCT06712433",
"title": "Bacterial Decolonization Plus Intraoperative Indocyanine Green Angiography for Soft Tissue Sarcomas of the Lower Extremity Receiving Preoperative Radiotherapy (CONCERTO)",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Adam Olson",
"sponsor_slug": "adam-olson",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07540832",
"publication_url": "https://clinicaltrials.gov/study/NCT07540832",
"title": "An Open-Label Phase 2 Study of WGI-0301 Plus Lenvatinib in Patients With Advanced Hepatocellular Carcinoma as Second Line Therapy",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Zhejiang Haichang Biotech Co., Ltd.",
"sponsor_slug": "zhejiang-haichang-biotech-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07179952",
"publication_url": "https://clinicaltrials.gov/study/NCT07179952",
"title": "A Study to Evaluate Efficacy and Safety of Slow Release DHEA",
"has_exemption": false,
"start_date": "2027-01-01",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Indiana University",
"sponsor_slug": "indiana-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04301843",
"publication_url": "https://clinicaltrials.gov/study/NCT04301843",
"title": "Phase II Trial of Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma",
"has_exemption": false,
"start_date": "2020-09-25",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Giselle Sholler",
"sponsor_slug": "giselle-sholler",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04269902",
"publication_url": "https://clinicaltrials.gov/study/NCT04269902",
"title": "Randomized, Phase III Study of Early Intervention With Venetoclax and Obinutuzumab Versus Delayed Therapy With Venetoclax and Obinutuzumab in Newly Diagnosed Asymptomatic High-Risk Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): EVOLVE CLL/SLL Study",
"has_exemption": false,
"start_date": "2021-03-02",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05058651",
"publication_url": "https://clinicaltrials.gov/study/NCT05058651",
"title": "Randomized Phase II/III Trial of First Line Platinum/Etoposide With or Without Atezolizumab (NSC#783608) in Patients With Poorly Differentiated Extrapulmonary Small Cell Neuroendocrine Carcinomas (NEC)",
"has_exemption": false,
"start_date": "2022-06-28",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05518188",
"publication_url": "https://clinicaltrials.gov/study/NCT05518188",
"title": "A Phase 1/2 Open-label Intrathecal Administration of MELPIDA to Determine Its Safety and Efficacy for Patients with Spastic Paraplegia Type 50 (SPG50) Caused by Mutation in the AP4M1 Gene.",
"has_exemption": false,
"start_date": "2023-02-15",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Elpida Therapeutics SPC",
"sponsor_slug": "elpida-therapeutics-spc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05554328",
"publication_url": "https://clinicaltrials.gov/study/NCT05554328",
"title": "A Randomized Trial of Selumetinib and Olaparib or Selumetinib Alone in Patients With Recurrent or Persistent RAS Pathway Mutant Ovarian and Endometrial Cancers: A ComboMATCH Treatment Trial",
"has_exemption": false,
"start_date": "2023-04-25",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06349434",
"publication_url": "https://clinicaltrials.gov/study/NCT06349434",
"title": "The Utilization Effects of Powered Wearable Orthotics in Improving Upper Extremity Function and ADL in Persons With SCI",
"has_exemption": false,
"start_date": "2023-10-15",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Kessler Foundation",
"sponsor_slug": "kessler-foundation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06099444",
"publication_url": "https://clinicaltrials.gov/study/NCT06099444",
"title": "The Effects of Muscle Synergy-Based Biofeedback During Gait Rehabilitation for Individuals With Chronic Stroke",
"has_exemption": false,
"start_date": "2024-03-19",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Shirley Ryan AbilityLab",
"sponsor_slug": "shirley-ryan-abilitylab",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06516978",
"publication_url": "https://clinicaltrials.gov/study/NCT06516978",
"title": "A Prospective, Open-Label, Multicenter, Randomized Controlled Study Comparing the Efficacy and Safety of Polatuzumab Vedotin, Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone Combined With Orelabrutinib/Chidamide/Venetoclax/Lenalidomide/PD1 (Pola-RCHP-X) Versus RCHOP-X and Pola-RCHP in Previously Untreated Patients With Diffuse Large B-Cell Lymphoma",
"has_exemption": false,
"start_date": "2024-10-01",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "The First Affiliated Hospital with Nanjing Medical University",
"sponsor_slug": "the-first-affiliated-hospital-with-nanjing-medical-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06635629",
"publication_url": "https://clinicaltrials.gov/study/NCT06635629",
"title": "Phase II Prospective Evaluation of Desmopressin Stimulation Test Performance in ACTH-dependent Cushing s Syndrome",
"has_exemption": false,
"start_date": "2024-12-12",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)",
"sponsor_slug": "national-institute-of-diabetes-and-digestive-and-kidney-diseases-niddk",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06644183",
"publication_url": "https://clinicaltrials.gov/study/NCT06644183",
"title": "A Phase 1/2, Open Label, Study of Roginolisib (IOA-244), an Orally Bioavailable, Selective PI3Kδ Inhibitor in Patients With Refractory/Relapsed Chronic Lymphocytic Leukemia (CLL) in Combination With Venetoclax and Rituximab",
"has_exemption": false,
"start_date": "2025-03-19",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Jennifer R. Brown, MD, PhD",
"sponsor_slug": "jennifer-r-brown-md-phd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06480760",
"publication_url": "https://clinicaltrials.gov/study/NCT06480760",
"title": "Effects of Carnosine In Patients With Peripheral Arterial Disease Patients; Randomized Intervention Trial (CIPHER)",
"has_exemption": false,
"start_date": "2025-05-20",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Shahid Baba",
"sponsor_slug": "shahid-baba",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07209449",
"publication_url": "https://clinicaltrials.gov/study/NCT07209449",
"title": "Phase II Study of ELacestrant in Combination With Abemaciclib or Elacestrant Alone In p53 Wild Type, Estrogen Receptor-positive Advanced or recurrenT Endometrial Cancer (ELITE)",
"has_exemption": false,
"start_date": "2025-10-01",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06986174",
"publication_url": "https://clinicaltrials.gov/study/NCT06986174",
"title": "A Phase 2 Study to Evaluate the Safety and Efficacy of Pacritinib in Relapsed or Refractory Waldenström Macroglobulinemia",
"has_exemption": false,
"start_date": "2025-11-21",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Shayna Sarosiek, MD",
"sponsor_slug": "shayna-sarosiek-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06408246",
"publication_url": "https://clinicaltrials.gov/study/NCT06408246",
"title": "Accelerating Cognition-guided Signatures to Enhance Translation in Depression Aim 3: Clinical Cognitive Trial",
"has_exemption": false,
"start_date": "2026-03-03",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07013591",
"publication_url": "https://clinicaltrials.gov/study/NCT07013591",
"title": "Randomized Clinical Trial of β Nicotinamide Mononucleotide in Patients Undergoing CABG Surgery",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Brigham and Women's Hospital",
"sponsor_slug": "brigham-and-womens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07434843",
"publication_url": "https://clinicaltrials.gov/study/NCT07434843",
"title": "PEMIGIST: Phase 2 Study of Pemigatinib (INCB054828) in the Treatment of Patients With Advanced SDH-deficient Gastrointestinal Stromal Tumor (GIST)",
"has_exemption": false,
"start_date": "2026-04-01",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Dana-Farber Cancer Institute",
"sponsor_slug": "dana-farber-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06833008",
"publication_url": "https://clinicaltrials.gov/study/NCT06833008",
"title": "An Open-label, Phase I/II First-in-human, Dose Escalation and Confirmation Study to Evaluate the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic and Anti-tumour Activity of IPN01195 as Single Agent in Adult Participants With Advanced Solid Tumours",
"has_exemption": false,
"start_date": "2025-03-14",
"completion_date": "2028-10-03",
"has_results": false,
"results_due": false,
"sponsor_name": "Ipsen",
"sponsor_slug": "ipsen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06202274",
"publication_url": "https://clinicaltrials.gov/study/NCT06202274",
"title": "Clinical Study to Evaluate the Safety and Efficacy of Candela Technology",
"has_exemption": false,
"start_date": "2023-10-04",
"completion_date": "2028-10-04",
"has_results": false,
"results_due": false,
"sponsor_name": "Candela Corporation",
"sponsor_slug": "candela-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06003387",
"publication_url": "https://clinicaltrials.gov/study/NCT06003387",
"title": "Phase 3b, Open-label, Multicenter, Single-dose Study Investigating Efficacy and Safety of CSL222 (Etranacogene Dezaparvovec) Gene Therapy Administered to Adult Subjects With Severe or Moderately Severe Hemophilia B With Detectable Pretreatment AAV5 Neutralizing Antibodies",
"has_exemption": false,
"start_date": "2024-01-30",
"completion_date": "2028-10-04",
"has_results": false,
"results_due": false,
"sponsor_name": "CSL Behring",
"sponsor_slug": "csl-behring",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05835310",
"publication_url": "https://clinicaltrials.gov/study/NCT05835310",
"title": "A Phase III, Randomized, Double-blind, Parallel-group, Placebo-controlled Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety of IV Anifrolumab in Pediatric Participants 5 to < 18 Years of Age With Moderate to Severe Active Systemic Lupus Erythematosus While on Background Standard of Care Therapy",
"has_exemption": false,
"start_date": "2024-03-14",
"completion_date": "2028-10-05",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07288034",
"publication_url": "https://clinicaltrials.gov/study/NCT07288034",
"title": "Immunotherapy Biomarker Collection for Metastatic NSCLC to Inform Adaptive Personalized Models Targeting Resistance (IMMUNO-BIOMAP)",
"has_exemption": false,
"start_date": "2026-04-08",
"completion_date": "2028-10-08",
"has_results": false,
"results_due": false,
"sponsor_name": "City of Hope Medical Center",
"sponsor_slug": "city-of-hope-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT00801489",
"publication_url": "https://clinicaltrials.gov/study/NCT00801489",
"title": "A Phase 2 Study of Fludarabine, Cytarabine, Filgrastim-sndz,Gemtuzumab Ozogamicin and Idarubicin in Newly Diagnosed Core Binding Factor Associated Acute Myelogenous Leukemia",
"has_exemption": false,
"start_date": "2007-04-04",
"completion_date": "2028-10-11",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT01878617",
"publication_url": "https://clinicaltrials.gov/study/NCT01878617",
"title": "A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma",
"has_exemption": false,
"start_date": "2013-06-23",
"completion_date": "2028-10-13",
"has_results": false,
"results_due": false,
"sponsor_name": "St. Jude Children's Research Hospital",
"sponsor_slug": "st-jude-childrens-research-hospital",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT06492291",
"publication_url": "https://clinicaltrials.gov/study/NCT06492291",
"title": "A Phase 3, Open-label Extension Study to Evaluate the Safety and Efficacy of MK-0616 in Adults With Hypercholesterolemia",
"has_exemption": false,
"start_date": "2024-08-05",
"completion_date": "2028-10-13",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07223047",
"publication_url": "https://clinicaltrials.gov/study/NCT07223047",
"title": "A Phase 1/2a, Open-Label, Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of BMS-986523 As Monotherapy and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies",
"has_exemption": false,
"start_date": "2025-11-25",
"completion_date": "2028-10-13",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06072781",
"publication_url": "https://clinicaltrials.gov/study/NCT06072781",
"title": "A Phase 3, Randomized, Open-Label Study of Combination Therapy With Avutometinib Plus Defactinib Versus Investigator's Choice of Treatment in Patients With Recurrent Low-Grade Serous Ovarian Cancer (LGSOC) (RAMP 301)",
"has_exemption": false,
"start_date": "2024-03-18",
"completion_date": "2028-10-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Verastem, Inc.",
"sponsor_slug": "verastem-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06815003",
"publication_url": "https://clinicaltrials.gov/study/NCT06815003",
"title": "Phase-2 Study of Vedolizumab Plus Post-Transplant Cyclophosphamide and Short Course Tacrolimus for Graft-versus-Host Disease Prevention After Reduced Intensity Conditioning Peripheral Blood Stem Cell Allogeneic Hematopoietic Cell Transplantation",
"has_exemption": false,
"start_date": "2025-04-18",
"completion_date": "2028-10-15",
"has_results": false,
"results_due": false,
"sponsor_name": "City of Hope Medical Center",
"sponsor_slug": "city-of-hope-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06796998",
"publication_url": "https://clinicaltrials.gov/study/NCT06796998",
"title": "Phase 2 Trial of Epcoritamab in Patients With Newly Diagnosed Marginal Zone Lymphoma (MZL)",
"has_exemption": false,
"start_date": "2025-10-13",
"completion_date": "2028-10-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Izidore Lossos, MD",
"sponsor_slug": "izidore-lossos-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04067336",
"publication_url": "https://clinicaltrials.gov/study/NCT04067336",
"title": "A Phase 1/2 First in Human Study of the Menin-MLL(KMT2A) Inhibitor KO-539 in Patients With Relapsed or Refractory Acute Myeloid Leukemia",
"has_exemption": false,
"start_date": "2019-09-12",
"completion_date": "2028-10-16",
"has_results": false,
"results_due": false,
"sponsor_name": "Kura Oncology, Inc.",
"sponsor_slug": "kura-oncology-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06572384",
"publication_url": "https://clinicaltrials.gov/study/NCT06572384",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Belimumab Administered Subcutaneously in Adults With Interstitial Lung Disease (ILD) Associated With Connective Tissue Disease (CTD)",
"has_exemption": false,
"start_date": "2024-09-11",
"completion_date": "2028-10-18",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07197944",
"publication_url": "https://clinicaltrials.gov/study/NCT07197944",
"title": "A Phase 3, Double-blind, Randomized, Parallel Group, Placebo-controlled, Multicenter Trial to Confirm the Efficacy and Safety of Glepaglutide 10 mg Twice Weekly, Followed by a Long-term, Open-label Safety Evaluation in Patients With Short Bowel Syndrome-intestinal Failure (SBS-IF)",
"has_exemption": false,
"start_date": "2026-02-11",
"completion_date": "2028-10-23",
"has_results": false,
"results_due": false,
"sponsor_name": "Zealand Pharma",
"sponsor_slug": "zealand-pharma",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07037004",
"publication_url": "https://clinicaltrials.gov/study/NCT07037004",
"title": "Impact of Microbiome Modulation With CBM588 in Combination With Pembrolizumab for Adjuvant Therapy of High-Risk, Resected Renal Cell Carcinoma (RCC)",
"has_exemption": false,
"start_date": "2026-05-04",
"completion_date": "2028-10-24",
"has_results": false,
"results_due": false,
"sponsor_name": "City of Hope Medical Center",
"sponsor_slug": "city-of-hope-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06818643",
"publication_url": "https://clinicaltrials.gov/study/NCT06818643",
"title": "A Phase 1/2 Open-label Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2025-03-25",
"completion_date": "2028-10-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07109414",
"publication_url": "https://clinicaltrials.gov/study/NCT07109414",
"title": "Randomized Phase 2/3 Trial of NP-G2-044 (Prilukae) Combined With PLD for Treatment of Platinum-Resistant Ovarian Cancer (ULTIMUS-1)",
"has_exemption": false,
"start_date": "2025-12-29",
"completion_date": "2028-10-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Novita Pharmaceuticals, Inc.",
"sponsor_slug": "novita-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07533942",
"publication_url": "https://clinicaltrials.gov/study/NCT07533942",
"title": "A Phase 2 Study to Investigate Efficacy, Safety, Tolerability, and Pharmacokinetics of JZP3507 (ONC206) in Adults With Recurrent Grade 2 or 3 Meningioma",
"has_exemption": false,
"start_date": "2026-06-01",
"completion_date": "2028-10-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Jazz Pharmaceuticals",
"sponsor_slug": "jazz-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02407028",
"publication_url": "https://clinicaltrials.gov/study/NCT02407028",
"title": "Hyperbaric Oxygen Brain Injury Treatment (HOBIT) Trial",
"has_exemption": false,
"start_date": "2018-06-25",
"completion_date": "2028-10-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Gaylan Rockswold",
"sponsor_slug": "gaylan-rockswold",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05755386",
"publication_url": "https://clinicaltrials.gov/study/NCT05755386",
"title": "A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Study to Evaluate the Efficacy and Safety of Iptacopan (LNP023) in Idiopathic Immune-complex-mediated Membranoproliferative Glomerulonephritis (IC-MPGN)",
"has_exemption": false,
"start_date": "2023-10-02",
"completion_date": "2028-10-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07461948",
"publication_url": "https://clinicaltrials.gov/study/NCT07461948",
"title": "Advanced MRI for Visualization and Quantification of the Tumor Immune Microenvironment (TIME) in Glioblastoma",
"has_exemption": false,
"start_date": "2025-10-27",
"completion_date": "2028-10-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Jonsson Comprehensive Cancer Center",
"sponsor_slug": "jonsson-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05451849",
"publication_url": "https://clinicaltrials.gov/study/NCT05451849",
"title": "A Phase 1/2 Single Arm Open-Label Clinical Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer",
"has_exemption": false,
"start_date": "2022-06-21",
"completion_date": "2028-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "TCR2 Therapeutics",
"sponsor_slug": "tcr2-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06430801",
"publication_url": "https://clinicaltrials.gov/study/NCT06430801",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled Program to Evaluate the Efficacy and Safety of Tulisokibart in Participants With Moderately to Severely Active Crohn's Disease",
"has_exemption": false,
"start_date": "2024-06-05",
"completion_date": "2028-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06678659",
"publication_url": "https://clinicaltrials.gov/study/NCT06678659",
"title": "A Phase 1 / 2, Open-Label Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer",
"has_exemption": false,
"start_date": "2024-11-21",
"completion_date": "2028-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Recursion Pharmaceuticals Inc.",
"sponsor_slug": "recursion-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05952453",
"publication_url": "https://clinicaltrials.gov/study/NCT05952453",
"title": "A Phase II Study in Newly Diagnosed Stage III/IV Epithelial Ovarian Cancer Evaluating Carbo/Taxol/Pembro in Patients Receiving Neoadjuvant Chemotherapy (NACT) Followed by Olaparib/Pembro Maintenance",
"has_exemption": false,
"start_date": "2025-02-17",
"completion_date": "2028-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Alabama at Birmingham",
"sponsor_slug": "university-of-alabama-at-birmingham",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06385262",
"publication_url": "https://clinicaltrials.gov/study/NCT06385262",
"title": "Safety, Efficacy, and Tumor Immune Microenvironment Changes With Neoadjuvant Chemotherapy and Cemiplimab With or Without Alirocumab in Stage 1B-3A Non-Small Cell Lung Cancer: TOP 2301",
"has_exemption": false,
"start_date": "2025-03-17",
"completion_date": "2028-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Duke University",
"sponsor_slug": "duke-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06787612",
"publication_url": "https://clinicaltrials.gov/study/NCT06787612",
"title": "Multi-Arm Phase 2 Platform Study of Ubamatamab (REGN4018; MUC16×CD3 Bispecific Antibody) With or Without Additional Agents in Platinum-Resistant Ovarian Cancer",
"has_exemption": false,
"start_date": "2025-05-28",
"completion_date": "2028-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06976619",
"publication_url": "https://clinicaltrials.gov/study/NCT06976619",
"title": "The Effect of Glycemic Control and of GLP-1 Receptor Agonism on Islet GLP-1 in People",
"has_exemption": false,
"start_date": "2025-10-03",
"completion_date": "2028-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07213817",
"publication_url": "https://clinicaltrials.gov/study/NCT07213817",
"title": "An Open-Label, Phase I/II First-in-Human, Dose Escalation, Dose Optimisation and Dose Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, Immunogenicity and Antitumour Activity of IPN60300 as Single Agent in Adult Participants With Locally Advanced or Metastatic Solid Tumours.",
"has_exemption": false,
"start_date": "2025-12-05",
"completion_date": "2028-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Ipsen",
"sponsor_slug": "ipsen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07308834",
"publication_url": "https://clinicaltrials.gov/study/NCT07308834",
"title": "Phase 1/2a Study to Evaluate the Safety and Tolerability Intra-articular CX-011 to Treat Moderate to Severe Pain From Knee Osteoarthritis",
"has_exemption": false,
"start_date": "2026-02-01",
"completion_date": "2028-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "CarthroniX, Inc.",
"sponsor_slug": "carthronix-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06065670",
"publication_url": "https://clinicaltrials.gov/study/NCT06065670",
"title": "A Randomized, Double-Blind, Delayed Treatment, Placebo-Controlled Trial to Assess the Changes in Multi-parametric MRI in Patients With Acute Demyelinating Lesions Taking Clemastine Fumarate as a Myelin Repair Therapy",
"has_exemption": false,
"start_date": "2026-09-15",
"completion_date": "2028-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03219359",
"publication_url": "https://clinicaltrials.gov/study/NCT03219359",
"title": "Maintenance in Autologous Stem Cell Transplant for Crohn's Disease (MASCT - CD)",
"has_exemption": false,
"start_date": "2018-02-22",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Aaron Etra",
"sponsor_slug": "aaron-etra",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03503331",
"publication_url": "https://clinicaltrials.gov/study/NCT03503331",
"title": "UAB Alzheimer's Disease Center Core Cohort - Imaging Substudy",
"has_exemption": false,
"start_date": "2018-04-20",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Alabama at Birmingham",
"sponsor_slug": "university-of-alabama-at-birmingham",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03614949",
"publication_url": "https://clinicaltrials.gov/study/NCT03614949",
"title": "Phase II Study of Stereotactic Body Radiation Therapy and Atezolizumab in the Management of Recurrent, Persistent, or Metastatic Cervical Cancer",
"has_exemption": false,
"start_date": "2019-01-29",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "H. Lee Moffitt Cancer Center and Research Institute",
"sponsor_slug": "h-lee-moffitt-cancer-center-and-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03833154",
"publication_url": "https://clinicaltrials.gov/study/NCT03833154",
"title": "A Phase III, Randomized, Placebo-controlled, Double-blind, Multi-center, International Study of Durvalumab With Stereotactic Body Radiation Therapy (SBRT) for the Treatment of Patients With Unresected Stage I/II, Lymph-node Negative Non-small Cell Lung Cancer (PACIFIC-4/RTOG-3515) Osimertinib Following SBRT, a Single Arm Cohort for Patients With Unresected Stage I/II, Lymph Node Negative NSCLC Harboring a Sensitizing EGFR Mutation",
"has_exemption": false,
"start_date": "2019-03-06",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03821129",
"publication_url": "https://clinicaltrials.gov/study/NCT03821129",
"title": "GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study",
"has_exemption": false,
"start_date": "2019-07-25",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "W.L.Gore & Associates",
"sponsor_slug": "wlgore-associates",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04230109",
"publication_url": "https://clinicaltrials.gov/study/NCT04230109",
"title": "A Phase 2 Study of Response-guided Neoadjuvant Sacituzumab Govitecan (IMMU-132) in Patients With Localized Triple-Negative Breast Cancer (NeoSTAR)",
"has_exemption": false,
"start_date": "2020-07-14",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04613596",
"publication_url": "https://clinicaltrials.gov/study/NCT04613596",
"title": "A Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination With Pembrolizumab Versus Pembrolizumab in Patients With Advanced Non-Small Cell Lung Cancer With KRAS G12C Mutation",
"has_exemption": false,
"start_date": "2020-12-02",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mirati Therapeutics Inc.",
"sponsor_slug": "mirati-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04411823",
"publication_url": "https://clinicaltrials.gov/study/NCT04411823",
"title": "Prediction of Post-laparoscopic Sleeve Gastrectomy Gastroesophageal Reflux Disease With an Endolumenal Functional Lumen Imaging Probe (EndoFLIP)",
"has_exemption": false,
"start_date": "2021-02-01",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06342960",
"publication_url": "https://clinicaltrials.gov/study/NCT06342960",
"title": "KYSA-3: A Phase 1/2, Open-Label, Multicenter Study of KYV-101, an Autologous Fully-Human Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis",
"has_exemption": false,
"start_date": "2022-12-01",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Kyverna Therapeutics",
"sponsor_slug": "kyverna-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05259904",
"publication_url": "https://clinicaltrials.gov/study/NCT05259904",
"title": "Study to Improve dEployment Related Asthma by Using L-citrulline Supplementation (SEALS)",
"has_exemption": false,
"start_date": "2023-03-08",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Denver",
"sponsor_slug": "university-of-colorado-denver",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05532943",
"publication_url": "https://clinicaltrials.gov/study/NCT05532943",
"title": "A Seamless Phase I/IIa Clinical Study to Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis",
"has_exemption": false,
"start_date": "2023-09-08",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Ever Supreme Bio Technology Co., Ltd.",
"sponsor_slug": "ever-supreme-bio-technology-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05977998",
"publication_url": "https://clinicaltrials.gov/study/NCT05977998",
"title": "A Phase II Study of Perioperative Paclitaxel in Patients With Gastric Adenocarcinoma and Carcinomatosis or Positive Cytology",
"has_exemption": false,
"start_date": "2023-09-08",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05821959",
"publication_url": "https://clinicaltrials.gov/study/NCT05821959",
"title": "A Trial of AAVAnc80-hOTOF Gene Therapy in Individuals With Sensorineural Hearing Loss Due to Otoferlin Gene Mutations",
"has_exemption": false,
"start_date": "2023-09-15",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Akouos, Inc.",
"sponsor_slug": "akouos-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06076304",
"publication_url": "https://clinicaltrials.gov/study/NCT06076304",
"title": "Nasal Steroids, Irrigation, Oral Antibiotics, and Subgroup Targeting for Effective Management of Acute Sinusitis",
"has_exemption": false,
"start_date": "2023-11-21",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Daniel Merenstein",
"sponsor_slug": "daniel-merenstein",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06140537",
"publication_url": "https://clinicaltrials.gov/study/NCT06140537",
"title": "Efficacy and Mechanisms of Dapagliflozin in Promoting Kidney Function and Cardiovascular Health in Kidney Transplant Recipients",
"has_exemption": false,
"start_date": "2024-02-01",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Denver",
"sponsor_slug": "university-of-colorado-denver",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05916235",
"publication_url": "https://clinicaltrials.gov/study/NCT05916235",
"title": "Photobiomodulation for Management of Temporomandibular Disorder Pain",
"has_exemption": false,
"start_date": "2024-02-08",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Florida",
"sponsor_slug": "university-of-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06572683",
"publication_url": "https://clinicaltrials.gov/study/NCT06572683",
"title": "Resonant Frequency rTMS: A Novel Approach to Target Circuit Modulation in Major Depressive Disorder",
"has_exemption": false,
"start_date": "2024-02-12",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, Los Angeles",
"sponsor_slug": "university-of-california-los-angeles",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06044623",
"publication_url": "https://clinicaltrials.gov/study/NCT06044623",
"title": "Implementing Geriatric Assessment for Dose Optimization of CDK 4/6-inhibitors in Older Breast Cancer Patients - a Pragmatic Randomized-controlled Trial (IMPORTANT Trial)",
"has_exemption": false,
"start_date": "2024-04-01",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Region Örebro County",
"sponsor_slug": "region-orebro-county",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06590857",
"publication_url": "https://clinicaltrials.gov/study/NCT06590857",
"title": "Phase 1b/2 Open-label Trial of 225Ac-DOTATATE (RYZ101) in Subjects With Estrogen Receptor-positive (ER+), Human Epidermal Growth Factor Receptor 2 (HER2)-Negative, Locally Advanced and Unresectable or Metastatic Breast Cancer Expressing Somatostatin Receptors (SSTRs) and Progressed After Antibody-drug Conjugates and/or Chemotherapy (TRACY-1).",
"has_exemption": false,
"start_date": "2024-07-19",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "RayzeBio, Inc.",
"sponsor_slug": "rayzebio-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06216301",
"publication_url": "https://clinicaltrials.gov/study/NCT06216301",
"title": "LUNAR-2: Pivotal, Randomized, Open-Label Study of Tumor Treating Fields (TTFields, 150 kHz) Concomitant With Pembrolizumab and Platinum-based Chemotherapy for the Treatment of Metastatic Non-Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2024-07-31",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "NovoCure GmbH",
"sponsor_slug": "novocure-gmbh",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06506422",
"publication_url": "https://clinicaltrials.gov/study/NCT06506422",
"title": "SGLT2 Inhibition as a Therapeutic Strategy to Reverse Arterial Stiffening in Aging",
"has_exemption": false,
"start_date": "2024-08-18",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Missouri-Columbia",
"sponsor_slug": "university-of-missouri-columbia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06806930",
"publication_url": "https://clinicaltrials.gov/study/NCT06806930",
"title": "Predicting Response to Neoadjuvant Endocrine Therapy (Neo-PREDICT)",
"has_exemption": false,
"start_date": "2024-10-01",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "George Washington University",
"sponsor_slug": "george-washington-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06330493",
"publication_url": "https://clinicaltrials.gov/study/NCT06330493",
"title": "Prospective Multi-Center Randomized Controlled Trial to Evaluate the Safety and Efficacy of AcoArt Litos Paclitaxel Coated Percutaneous Transluminal Angioplasty (PTA) Balloon Versus Non-Coated Standard Balloon Angioplasty for the Treatment of Infrapopliteal Obstructions in Patients With Chronic Limb-Threatening Ischemia",
"has_exemption": false,
"start_date": "2024-10-10",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Acotec Scientific Co., Ltd",
"sponsor_slug": "acotec-scientific-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05903131",
"publication_url": "https://clinicaltrials.gov/study/NCT05903131",
"title": "UPLifT-Endo: Uterine Preservation Via Lifestyle Transformation A Behavioral Intervention to Promote Primary Prevention and Uterine Preservation in Premenopausal Women With Obesity and Atypical Endometrial Hyperplasia or Grade 1 Endometrial Cancer",
"has_exemption": false,
"start_date": "2024-10-24",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06733935",
"publication_url": "https://clinicaltrials.gov/study/NCT06733935",
"title": "A Phase 1/2 Study of NKX019, a CD19 Chimeric Antigen Receptor Natural Killer (CAR NK) Cell Therapy, in Subjects With Immune-Mediated Diseases",
"has_exemption": false,
"start_date": "2024-11-04",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Nkarta, Inc.",
"sponsor_slug": "nkarta-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06614192",
"publication_url": "https://clinicaltrials.gov/study/NCT06614192",
"title": "AndroMETa-CRC-064: An Open Label, Randomized, Controlled, Global Phase 3 Study Comparing Telisotuzumab Adizutecan (ABBV-400) Monotherapy to LONSURF (Trifluridine and Tipiracil) Plus Bevacizumab in Subjects With Refractory Metastatic Colorectal Cancer Expressing c-Met Protein Level Above a Defined Cutoff",
"has_exemption": false,
"start_date": "2024-11-08",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06825689",
"publication_url": "https://clinicaltrials.gov/study/NCT06825689",
"title": "Unidos Contra el VPH: Screening Preference and Uptake of HPV Self-sampling Among Latinxs Along the US-Mexico Border",
"has_exemption": false,
"start_date": "2025-01-28",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas at Austin",
"sponsor_slug": "university-of-texas-at-austin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06942572",
"publication_url": "https://clinicaltrials.gov/study/NCT06942572",
"title": "A Phase 1/2, First-in-Human, Open-label, Assessor-Masked, Randomized, Controlled, Dose Escalation/Expansion Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Subretinal Injection of SB-007 in Subjects With Stargardt Disease (STGD1) Caused by Bi-Allelic Autosomal Recessive Mutations in the ATP Binding Cassette Subfamily A Member 4 (ABCA4) Gene",
"has_exemption": false,
"start_date": "2025-02-11",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Splice Bio",
"sponsor_slug": "splice-bio",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06841055",
"publication_url": "https://clinicaltrials.gov/study/NCT06841055",
"title": "A Phase II, Multisite, Open-label Trial of Pumitamig (BNT327) in Combination With Standard-of-care Chemotherapy in First-line and Second-line Non-small Cell Lung Cancer (NSCLC)",
"has_exemption": false,
"start_date": "2025-03-03",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Biontech SE",
"sponsor_slug": "biontech-se",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06817668",
"publication_url": "https://clinicaltrials.gov/study/NCT06817668",
"title": "Evaluating Tolerability of Elective Pelvic Ultra Hypofractionated Irradiation Treatment (ePUHRT) With High Dose Rate Brachytherapy Boost for Unfavorable and Higher Risk Prostate Cancer",
"has_exemption": false,
"start_date": "2025-03-05",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Indiana University",
"sponsor_slug": "indiana-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06533865",
"publication_url": "https://clinicaltrials.gov/study/NCT06533865",
"title": "Romosozumab as an Adjunct to Physiologic Estrogen Replacement in Adolescents and Young Adults With Functional Hypothalamic Amenorrhea",
"has_exemption": false,
"start_date": "2025-03-19",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06635811",
"publication_url": "https://clinicaltrials.gov/study/NCT06635811",
"title": "Circadian Adaptive Deep Brain Stimulation in Essential Tremor",
"has_exemption": false,
"start_date": "2025-05-01",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Florida",
"sponsor_slug": "university-of-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06727773",
"publication_url": "https://clinicaltrials.gov/study/NCT06727773",
"title": "Memantine and Exercise to Improve Cognitive Function and Modulate Biological Pathways of Cognitive Decline During Chemotherapy in Breast Cancer",
"has_exemption": false,
"start_date": "2025-05-07",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "UNC Lineberger Comprehensive Cancer Center",
"sponsor_slug": "unc-lineberger-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06960577",
"publication_url": "https://clinicaltrials.gov/study/NCT06960577",
"title": "A Phase IIIb, Open-label, Single-arm, Global Study of Perioperative Durvalumab With Neoadjuvant ddMVAC or Gem/Cis in Patients With Muscle-invasive Bladder Cancer (NIAGARA-2)",
"has_exemption": false,
"start_date": "2025-05-15",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06680752",
"publication_url": "https://clinicaltrials.gov/study/NCT06680752",
"title": "A Phase 1/2, Open-label, Multicenter Trial to Assess the Safety and Efficacy of ARD103 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome",
"has_exemption": false,
"start_date": "2025-05-20",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "ARCE Therapeutics, Inc.",
"sponsor_slug": "arce-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06693011",
"publication_url": "https://clinicaltrials.gov/study/NCT06693011",
"title": "Contour Neurovascular System™ ContiNued Access Investigational Device EXempTion (IDE) Trial",
"has_exemption": false,
"start_date": "2025-06-10",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Cerus Endovascular, Inc.",
"sponsor_slug": "cerus-endovascular-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06328608",
"publication_url": "https://clinicaltrials.gov/study/NCT06328608",
"title": "Multi-centre, Open-label Trial to Assess the saFety, Pharmacodynamics, Efficacy and Pharmacokinetics of pegunigaLsidase Alfa in Patients From 2 Years to Less Than 18 Years of Age With Confirmed FabrY Disease",
"has_exemption": false,
"start_date": "2025-07-29",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Chiesi Farmaceutici S.p.A.",
"sponsor_slug": "chiesi-farmaceutici-spa",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07416149",
"publication_url": "https://clinicaltrials.gov/study/NCT07416149",
"title": "Reducing Post-operative Hypoparathyroidism With Probe-based Near Infrared Autofluorescence (NIRAF)- Assisted Total Thyroidectomy Versus Conventional Total Thyroidectomy, a Randomized-controlled Trial",
"has_exemption": false,
"start_date": "2025-09-16",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Hong Kong",
"sponsor_slug": "the-university-of-hong-kong",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07224256",
"publication_url": "https://clinicaltrials.gov/study/NCT07224256",
"title": "VOICE: An Early Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for Communication Restoration",
"has_exemption": false,
"start_date": "2025-10-03",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Neuralink Corp",
"sponsor_slug": "neuralink-corp",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06784336",
"publication_url": "https://clinicaltrials.gov/study/NCT06784336",
"title": "Phase II Multi-center Study of Resistant Potato Starch Plus Deferasirox to Improve Outcomes in Patients Undergoing Allogeneic Stem Cell Transplantation",
"has_exemption": false,
"start_date": "2025-10-15",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Michigan Rogel Cancer Center",
"sponsor_slug": "university-of-michigan-rogel-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07115004",
"publication_url": "https://clinicaltrials.gov/study/NCT07115004",
"title": "A Prospective, Multicenter, Open-label, Phase 3 Clinical Study to Evaluate the Efficacy and Safety of Prophylactic VGA039 in Adolescent and Adult Patients With Von Willebrand Disease (VIVID-6)",
"has_exemption": false,
"start_date": "2025-10-15",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Vega Therapeutics, Inc",
"sponsor_slug": "vega-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07045194",
"publication_url": "https://clinicaltrials.gov/study/NCT07045194",
"title": "A Prospective, Multi-center, Single-blind, Randomized (1:1), Non-inferiority Study Comparing Clinical Outcomes of the Virtue® Sirolimus AngioInfusion™ Balloon (SAB) to the AGENT™ Paclitaxel Drug-Coated Balloon (DCB) in the Treatment of Coronary Artery In-stent Restenosis (ISR).",
"has_exemption": false,
"start_date": "2025-10-20",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Orchestra BioMed, Inc",
"sponsor_slug": "orchestra-biomed-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07194850",
"publication_url": "https://clinicaltrials.gov/study/NCT07194850",
"title": "A Multicenter, Randomized, Double-blinded, Parallel-Arm, Placebo-Controlled, Pharmacokinetic and Pharmacodynamic Study Followed by an Open-Label Arm to Evaluate Efgartigimod IV in Pediatric Participants From 12 Years to Less Than 18 Years of Age With Chronic ITP",
"has_exemption": false,
"start_date": "2025-10-20",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "argenx",
"sponsor_slug": "argenx",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07223021",
"publication_url": "https://clinicaltrials.gov/study/NCT07223021",
"title": "Improving EveNt Free Survival by Optimizing FLUdarabine Exposure During LymphodepletioN for CAR T CEll Therapy: a Randomized, Multi-center Study of Children and Young Adults With B-cell Acute Lymphoblastic Leukemia (INFLUENCE)",
"has_exemption": false,
"start_date": "2025-10-20",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06878560",
"publication_url": "https://clinicaltrials.gov/study/NCT06878560",
"title": "EXPAND: A Prospective Study to Evaluate the Safety and Efficacy of the 10 GE Xenokidney in Patients With End-stage Renal Disease (ESRD)",
"has_exemption": false,
"start_date": "2025-10-29",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "United Therapeutics",
"sponsor_slug": "united-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07191912",
"publication_url": "https://clinicaltrials.gov/study/NCT07191912",
"title": "A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Long-Term Clinical Benefit of Govorestat in Patients With Charcot-Marie-Tooth-Sorbitol Dehydrogenase Deficiency (CMT-SORD)",
"has_exemption": false,
"start_date": "2025-10-31",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Applied Therapeutics, Inc.",
"sponsor_slug": "applied-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07225751",
"publication_url": "https://clinicaltrials.gov/study/NCT07225751",
"title": "A Prospective, Randomized, Single-blind, Controlled, Multi-center Study to Assess the Safety and Performance of MagnetOsTM Compared to Autogenous Bone Graft in Patients Undergoing Hindfoot or Ankle Fusions",
"has_exemption": false,
"start_date": "2025-11-25",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Kuros Biosurgery AG",
"sponsor_slug": "kuros-biosurgery-ag",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07357415",
"publication_url": "https://clinicaltrials.gov/study/NCT07357415",
"title": "A Phase 3b Study to Investigate the Efficacy and Safety of Different Retatrutide Dose Escalation Schemes in Participants Without Type 2 Diabetes Who Have Obesity or Overweight: A Randomized, Controlled, Double-Blind Trial",
"has_exemption": false,
"start_date": "2026-01-24",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06510309",
"publication_url": "https://clinicaltrials.gov/study/NCT06510309",
"title": "A Phase II Study Using Rituximab Plus Venetoclax in the Front Line Treatment of Marginal Zone Lymphoma",
"has_exemption": false,
"start_date": "2026-02-11",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Gottfried von Keudell, MD PhD",
"sponsor_slug": "gottfried-von-keudell-md-phd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07389590",
"publication_url": "https://clinicaltrials.gov/study/NCT07389590",
"title": "A Pilot Study of Ublituximab in People With MS Experiencing Wearing Off Phenomena While Receiving Treatment With Ocrelizumab",
"has_exemption": false,
"start_date": "2026-02-28",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Johns Hopkins University",
"sponsor_slug": "johns-hopkins-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07291297",
"publication_url": "https://clinicaltrials.gov/study/NCT07291297",
"title": "Metformin Hydrochloride in Combination With Standard of Care Systemic Therapy in Previously Untreated Advanced Unresectable or Metastatic Soft Tissue Sarcoma",
"has_exemption": false,
"start_date": "2026-03-04",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Wake Forest University Health Sciences",
"sponsor_slug": "wake-forest-university-health-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07062354",
"publication_url": "https://clinicaltrials.gov/study/NCT07062354",
"title": "A Phase II Study of Combined Amivantamab, Carboplatin and Paclitaxel in Unresectable Locally Recurrent or Metastatic Head and Neck Cancer",
"has_exemption": false,
"start_date": "2026-03-25",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "SWOG Cancer Research Network",
"sponsor_slug": "swog-cancer-research-network",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07225270",
"publication_url": "https://clinicaltrials.gov/study/NCT07225270",
"title": "A Randomized, Open-Label, Phase 3 Study of Rinatabart Sesutecan (Rina-S) Plus Standard of Care Versus Standard of Care as Maintenance Treatment After 2L Platinum-Based Doublet Chemotherapy in Participants With Recurrent Platinum-Sensitive Ovarian Cancer (PSOC)",
"has_exemption": false,
"start_date": "2026-04-03",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Genmab",
"sponsor_slug": "genmab",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06891885",
"publication_url": "https://clinicaltrials.gov/study/NCT06891885",
"title": "A Prospective, Open-label, Single-arm, Dose-escalation Study of the Safety and Tolerability of a Single Subretinal Uniocular Injection of Allogeneic Induced Pluripotent Stem Cell (iPSC)-Derived Retinal Sheets (DSP-3077) in Adults With Retinitis Pigmentosa (RP)",
"has_exemption": false,
"start_date": "2026-04-16",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Sumitomo Pharma America, Inc.",
"sponsor_slug": "sumitomo-pharma-america-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06205589",
"publication_url": "https://clinicaltrials.gov/study/NCT06205589",
"title": "A Phase 2a/2b Study Evaluating Safety, Immunogenicity, and Therapeutic Efficacy of ID93 + GLA-SE Vaccination in Participants With Rifampicin-Susceptible Pulmonary TB",
"has_exemption": false,
"start_date": "2026-07-01",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections",
"sponsor_slug": "advancing-clinical-therapeutics-globally-for-hivaids-and-other-infections",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05882344",
"publication_url": "https://clinicaltrials.gov/study/NCT05882344",
"title": "Cholinergic Deep Brain Stimulation for Alzheimer's Disease",
"has_exemption": false,
"start_date": "2026-07-31",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Vanderbilt University Medical Center",
"sponsor_slug": "vanderbilt-university-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07290777",
"publication_url": "https://clinicaltrials.gov/study/NCT07290777",
"title": "A Phase 2, Randomized, Partially Blinded, Controlled, Dose-ranging Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of VEL-101 in Kidney Transplant Recipients.",
"has_exemption": false,
"start_date": "2026-07-31",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Veloxis Pharmaceuticals",
"sponsor_slug": "veloxis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07135687",
"publication_url": "https://clinicaltrials.gov/study/NCT07135687",
"title": "Oral Losartan to Decrease the Risk of Postoperative Arthrofibrosis Following Primary and Revision Anterior Cruciate Ligament Reconstruction",
"has_exemption": false,
"start_date": "2026-08-31",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Rush University Medical Center",
"sponsor_slug": "rush-university-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06272201",
"publication_url": "https://clinicaltrials.gov/study/NCT06272201",
"title": "Incisionless Suture Plications in a POSE2.0 Interventional Randomized Obesity Study (The INSPIRO Study)",
"has_exemption": false,
"start_date": "2026-10-31",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "USGI Medical",
"sponsor_slug": "usgi-medical",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06916325",
"publication_url": "https://clinicaltrials.gov/study/NCT06916325",
"title": "DeLIVER Trial: A Prospective, Multi-Center, Single-Arm, Open Label Trial of Deceased Donor Livers Transplanted After DHOPE With eXVIVO LIVER Perfusion",
"has_exemption": false,
"start_date": "2027-01-31",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "XVIVO Perfusion",
"sponsor_slug": "xvivo-perfusion",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05517655",
"publication_url": "https://clinicaltrials.gov/study/NCT05517655",
"title": "BEGIN Novel ImagiNG Biomarkers",
"has_exemption": false,
"start_date": "2022-05-01",
"completion_date": "2028-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Hospital Medical Center, Cincinnati",
"sponsor_slug": "childrens-hospital-medical-center-cincinnati",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06080503",
"publication_url": "https://clinicaltrials.gov/study/NCT06080503",
"title": "G-FORCE: Phase II Randomized Study of Glottic Larynx Hypofractionated Radiotherapy Versus ConvEntional Radiotherapy",
"has_exemption": false,
"start_date": "2024-03-14",
"completion_date": "2028-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas Southwestern Medical Center",
"sponsor_slug": "university-of-texas-southwestern-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06709495",
"publication_url": "https://clinicaltrials.gov/study/NCT06709495",
"title": "Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas",
"has_exemption": false,
"start_date": "2025-01-27",
"completion_date": "2028-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "David S Shulman, MD",
"sponsor_slug": "david-s-shulman-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06819007",
"publication_url": "https://clinicaltrials.gov/study/NCT06819007",
"title": "A Phase 3, Open-label, Multicenter, Randomized Trial of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy as First-line Maintenance Therapy in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01/ENGOT-ov89/GEICO144- O/GOG-3112/APGOT-OV13)",
"has_exemption": false,
"start_date": "2025-03-19",
"completion_date": "2028-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Daiichi Sankyo",
"sponsor_slug": "daiichi-sankyo",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06973629",
"publication_url": "https://clinicaltrials.gov/study/NCT06973629",
"title": "A Two-Part Phase 3b Randomized, Double-Blind, Placebo-Controlled, Followed by Open-Label Extension, Multicenter Study of the Efficacy and Safety of MSC-NTF (NurOwn) in Participants With With Early Symptomatic and Moderate Disease Presentation in Amyotrophic Lateral Sclerosis (ALS)",
"has_exemption": false,
"start_date": "2025-06-30",
"completion_date": "2028-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Brainstorm-Cell Therapeutics",
"sponsor_slug": "brainstorm-cell-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07217301",
"publication_url": "https://clinicaltrials.gov/study/NCT07217301",
"title": "A Randomized, Open-Label, Multi-center, Phase 3 Study Evaluating the Efficacy and Safety of IBI363 Versus Docetaxel in Participants With Unresectable Locally Advanced or Metastatic Squamous Non-Small Cell Lung Cancer With Disease Progression on or After Platinum-Based Chemotherapy and Anti-PD-1/PD-L1 Immunotherapy",
"has_exemption": false,
"start_date": "2025-11-26",
"completion_date": "2028-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Fortvita Biologics (USA)Inc.",
"sponsor_slug": "fortvita-biologics-usainc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07283731",
"publication_url": "https://clinicaltrials.gov/study/NCT07283731",
"title": "Phase 2 Trial of Zanzalintinib and Pembrolizumab in Select Subtypes of Advanced/Metastatic Soft-tissue Sarcoma",
"has_exemption": false,
"start_date": "2026-06-02",
"completion_date": "2028-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07126561",
"publication_url": "https://clinicaltrials.gov/study/NCT07126561",
"title": "Phase II Open Label Trial of Trastuzumab Deruxtecan (Enhertu, DS-8210) in HER2 Positive Newly Diagnosed Metastatic Esophageal, Gastric, GEJ Cancer Patients With an ECOG Performance Status of 2",
"has_exemption": false,
"start_date": "2026-11-01",
"completion_date": "2028-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Chicago",
"sponsor_slug": "university-of-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07538336",
"publication_url": "https://clinicaltrials.gov/study/NCT07538336",
"title": "Targeting Interferon Gamma With Emapalumab to Lung Transplant Recipients With Interferon Gamma-high Acute Lung Allograft Dysfunction",
"has_exemption": false,
"start_date": "2026-11-02",
"completion_date": "2028-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05931484",
"publication_url": "https://clinicaltrials.gov/study/NCT05931484",
"title": "A Phase 2, Double-Blind, Multi-Center, Placebo-Controlled Clinical Study to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetics of FHL-301 in Adult Patients With Parkinson's Disease",
"has_exemption": false,
"start_date": "2027-11-01",
"completion_date": "2028-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Forest Hills Lab",
"sponsor_slug": "forest-hills-lab",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06152237",
"publication_url": "https://clinicaltrials.gov/study/NCT06152237",
"title": "A Multicenter, Open Label, Randomized, Dose-Escalation and Dose-Expansion Study of the Safety, Tolerability, and Efficacy of a Single Intrathecal Administration of TSHA-102, an AAV9-Delivered Gene Therapy, for the Treatment of Pediatric Females With Rett Syndrome",
"has_exemption": false,
"start_date": "2023-12-12",
"completion_date": "2028-11-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Taysha Gene Therapies, Inc.",
"sponsor_slug": "taysha-gene-therapies-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07011745",
"publication_url": "https://clinicaltrials.gov/study/NCT07011745",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease",
"has_exemption": false,
"start_date": "2025-07-16",
"completion_date": "2028-11-03",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06189313",
"publication_url": "https://clinicaltrials.gov/study/NCT06189313",
"title": "A Prospective, Multicenter Study to Evaluate the Safety and Efficacy of an Aspiration Thrombectomy System in Acute Pulmonary Embolism",
"has_exemption": false,
"start_date": "2025-01-03",
"completion_date": "2028-11-04",
"has_results": false,
"results_due": false,
"sponsor_name": "Argon Medical Devices",
"sponsor_slug": "argon-medical-devices",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07160244",
"publication_url": "https://clinicaltrials.gov/study/NCT07160244",
"title": "A Phase 3, Randomized, Placebo-Controlled, Double-Blinded Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Multivalent Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Infants",
"has_exemption": false,
"start_date": "2025-08-25",
"completion_date": "2028-11-06",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06504394",
"publication_url": "https://clinicaltrials.gov/study/NCT06504394",
"title": "A Phase 2 Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Pembrolizumab Coformulated With Hyaluronidase (MK-3475A) in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma (rrcHL) or Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma (rrPMBCL)",
"has_exemption": false,
"start_date": "2024-10-14",
"completion_date": "2028-11-08",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04375800",
"publication_url": "https://clinicaltrials.gov/study/NCT04375800",
"title": "A Phase 2 Clinical Study to Evaluate the Pharmacokinetics, Safety, and Efficacy of Doravirine and Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate in Participants With HIV-1, Who Are 4 Weeks to Less Than 12 Years of Age and Weigh Less Than 45 kg",
"has_exemption": false,
"start_date": "2021-02-03",
"completion_date": "2028-11-12",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06161519",
"publication_url": "https://clinicaltrials.gov/study/NCT06161519",
"title": "Phase I/II Trial of PLX038 in Primary Central Nervous System Tumors With and Without MYC or MYCN Amplifications",
"has_exemption": false,
"start_date": "2024-01-31",
"completion_date": "2028-11-14",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07301034",
"publication_url": "https://clinicaltrials.gov/study/NCT07301034",
"title": "Effects of Ziltivekimab Versus Placebo on Coronary Atherosclerosis in Patients With Acute Myocardial Infarction. A Serial, Multivessel, Intravascular Ultrasound, Near-infrared Spectroscopy and Optical Coherence Tomography Imaging Study",
"has_exemption": false,
"start_date": "2025-12-18",
"completion_date": "2028-11-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Novo Nordisk A/S",
"sponsor_slug": "novo-nordisk-as",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07335562",
"publication_url": "https://clinicaltrials.gov/study/NCT07335562",
"title": "A Phase 3, Randomized, Open-label, Multicenter Study to Compare the Efficacy and Safety of BMS-986353, CD19-targeted NEX-T CAR T Cells, Versus Standard of Care in Participants With Active Systemic Sclerosis (Breakfree-SSc)",
"has_exemption": false,
"start_date": "2026-04-30",
"completion_date": "2028-11-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Juno Therapeutics, Inc., a Bristol-Myers Squibb Company",
"sponsor_slug": "juno-therapeutics-inc-a-bristol-myers-squibb-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04626024",
"publication_url": "https://clinicaltrials.gov/study/NCT04626024",
"title": "Safety And Efficacy Of Tyrosine Kinase Inhibitor Cessation For Chronic Myeloid Leukemia Patients With Stable Molecular Response In A Real World Population",
"has_exemption": false,
"start_date": "2020-12-22",
"completion_date": "2028-11-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Baylor College of Medicine",
"sponsor_slug": "baylor-college-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05051033",
"publication_url": "https://clinicaltrials.gov/study/NCT05051033",
"title": "Percutaneous or Surgical Repair In Mitral Prolapse And Regurgitation for ≥60 Year-olds (PRIMARY)",
"has_exemption": false,
"start_date": "2022-02-21",
"completion_date": "2028-11-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Annetine Gelijns",
"sponsor_slug": "annetine-gelijns",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06144606",
"publication_url": "https://clinicaltrials.gov/study/NCT06144606",
"title": "Phase 2 Study of KTE-X19 in Minimal Residual Disease (MRD) Positive B-Cell Acute Lymphoblastic Leukemia (B-ALL)",
"has_exemption": false,
"start_date": "2023-12-26",
"completion_date": "2028-11-15",
"has_results": false,
"results_due": false,
"sponsor_name": "H. Lee Moffitt Cancer Center and Research Institute",
"sponsor_slug": "h-lee-moffitt-cancer-center-and-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06571383",
"publication_url": "https://clinicaltrials.gov/study/NCT06571383",
"title": "Weight Maintenance in Adolescents With Obesity; Long-Term Treatment With Semaglutide s.c.2.4 mg Once-weekly",
"has_exemption": false,
"start_date": "2024-09-17",
"completion_date": "2028-11-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Novo Nordisk A/S",
"sponsor_slug": "novo-nordisk-as",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07092527",
"publication_url": "https://clinicaltrials.gov/study/NCT07092527",
"title": "Androgen Effects on the Reproductive Neuroendocrine Axis, 2025 Version",
"has_exemption": false,
"start_date": "2025-12-05",
"completion_date": "2028-11-15",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Diego",
"sponsor_slug": "university-of-california-san-diego",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07214779",
"publication_url": "https://clinicaltrials.gov/study/NCT07214779",
"title": "A Phase 3, Randomized, Open-Label Study of INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression",
"has_exemption": false,
"start_date": "2025-12-09",
"completion_date": "2028-11-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Incyte Corporation",
"sponsor_slug": "incyte-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05490277",
"publication_url": "https://clinicaltrials.gov/study/NCT05490277",
"title": "Vibrotactile Coordinated Reset for the Treatment of Chronic Stroke",
"has_exemption": false,
"start_date": "2026-01-15",
"completion_date": "2028-11-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07411599",
"publication_url": "https://clinicaltrials.gov/study/NCT07411599",
"title": "Dual Administration Of Intraperitoneal And Intravenous TROP2-Directed CAR-NK With TGF-Beta Receptor 2 (TGFBR2) Knock Out (KO) Therapy For Colorectal Cancer-Related Peritoneal Carcinomatosis: A Phase 1/2 Trial (\"Chip-CRC Trial\")",
"has_exemption": false,
"start_date": "2026-04-20",
"completion_date": "2028-11-15",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07499232",
"publication_url": "https://clinicaltrials.gov/study/NCT07499232",
"title": "A Phase 3b, Multicenter, Randomized, Open-Label, Active-Controlled Study to Compare the Efficacy and Safety of Guselkumab Versus Risankizumab in the Treatment of Participants With Moderately to Severely Active Crohn's Disease",
"has_exemption": false,
"start_date": "2026-04-20",
"completion_date": "2028-11-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07218809",
"publication_url": "https://clinicaltrials.gov/study/NCT07218809",
"title": "A Randomised, Open-label, Phase III Study of AZD5335 Versus Mirvetuximab Soravtansine in FRα-high and AZD5335 Versus Investigator's Choice Chemotherapy in FRα-low Expressing High-grade Platinum-resistant Epithelial Ovarian Cancer Patients (TREVI-OC-01)",
"has_exemption": false,
"start_date": "2025-12-29",
"completion_date": "2028-11-17",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06499870",
"publication_url": "https://clinicaltrials.gov/study/NCT06499870",
"title": "Optimizing Treatment and Advanced Multi-Imaging Response Evaluation for Very-High-Risk Prostate Cancer (OPTIMAL) - a Phase II Single Arm Study",
"has_exemption": false,
"start_date": "2024-09-06",
"completion_date": "2028-11-19",
"has_results": false,
"results_due": false,
"sponsor_name": "Northwestern University",
"sponsor_slug": "northwestern-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
}
]
}